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Summary 
Tissue repair and fibrosis are controlled by the interaction of different cell lineages, their 
soluble factors and matrix signals. Recently, macrophages have been found to be crucial 
for proper tissue repair. In particular, the role of Transforming growth factor-β1 (TGF-β1) 
has been extensively studied during tissue repair and fibrosis. Fibrosis is characterized by 
excessive production and deposition of extracellular matrix, as well as immune cell 
infiltration. Macrophages are one of the main sources of TGF-β1. So far, studies on the 
mechanisms of tissue repair and fibrosis have mainly focused on macrophages or TGF-β1 
individually. However, the specific function of TGF-β1 on macrophages in tissue repair 
and fibrosis still needs to be elucidated. 
To understand the macrophage specific role of TGFβ1-TGFβRII signaling in tissue repair 
and fibrosis, we generated a mouse model, which lacks TGFβRII in myeloid cells 
(TGFβRIIfl/fl/LysMCre). We observed that during mechanical tissue injury TGFβRII 
signaling in macrophages contributes to wound contraction, possibly by cross—talk 
between macrophages and fibroblasts. The attenuated wound contraction was 
accompanied by impaired myofibroblast differentiation and collagen deposition. However, 
the loss of TGFβRII signaling in macrophages did not lead to reduced expression of TGF-
β1, which we proposed as one of the primary mechanisms in wound tissue underlying 
reduced myofibroblast formation observed in TGFβRIIfl/fl/LysMCre mice.  
Generation of cutaneous fibrosis by bleomycin injection for two and four weeks resulted in 
reduced fibrosis in TGFβRIIfl/fl/LysMCre mice, compared to control mice. The mechanisms 
leading to this phenotype were associated with reduced infiltration of immune cells, 
reduced deposition of collagen and diminished production of inflammatory mediators such 
as IL-1β, TNF-α and osteopontin-1 at the early stage of fibrosis formation. At the later 
stage, the expression of inflammatory mediators in TGFβRIIfl/fl/LysMCre mice was not 
altered compared to control mice, possibly due to compensatory mechanisms. Our data 
leads to the hypothesis that the reduced fibrosis is caused by the reduced expression of 
inflammatory mediators and accumulation of immune cells at the early stage of fibrosis in 
TGFβRIIfl/fl/LysMCre mice.  
 
Our results provide new insights into the crucial role of macrophage specific TGFβRII 
signaling in tissue repair and fibrosis. 
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Zusammenfassung 
Die Gewebereparatur, als auch die Fibrose sind durch die Interaktion unterschiedlicher 
Zellen zueinander, löslicher Faktoren und über den Kontakt zur extrazellulären Matrix 
reguliert. Makrophagen sind wichtige Regulatoren in der physiologischen und 
pathologischen Wundheilung. TGF-β1 gilt als zentraler Wachstumsfaktor zur Regulation 
epidermaler und mesenchymaler Reparaturprozesse. Die Entstehung von Fibrose ist 
maßgeblich durch eine Fehlregulation der Homöostase der extrazellulären Matrix und der 
Infiltration von Immunzellen charakterisiert, wobei Makrophagen eine entscheidende Rolle 
zu spielen scheinen. Bisher ist über die Bedeutung von TGF-β1 auf die 
Makrophagenfunktion in der Wundheilung wenig bekannt. 
Um dieser Fragestellung nachzugehen, wurde ein Mausmodell generiert in dem TGFβRII 
spezifisch in myeloiden Zellen deletiert wird (TGFβRII/LysMCre). Anhand dieses Modells 
konnten wir zeigen, dass die TGFβRII vermittelte Signalkaskade in Makrophagen 
maßgeblich zur Wundkontraktion beiträgt. Diese wird möglicherweise durch eine 
parakrine Interaktion von Makrophagen und Fibroblasten vermittelt. Die veränderte 
Wundkontraktion in TGFβRII/LysMCre Mäusen geht einher mit einer beeinträchtigten 
Myofibroblastendifferenzierung und einer verminderten Kollagensynthese. Die Deletion 
des TGF-β1 Rezeptors in Makrophagen führt nicht zu einer verminderten Expression von 
TGF-β1 im Wundgewebe von TGFβRII/LysMCre Tieren, was möglicherweise den 
beschriebenen Phänotypen hätte erklären können. 
Die Bleomycin-induzierte Hautfibrose führt in TGFβRII/LysMCre Mäusen zu einer 
signifikant verminderten Fibrosereaktion. Die Tiere weisen nach zweiwöchiger Injektion 
ein verringertes Entzündungsfiltrat, eine verminderte Kollagenablagerung, als auch 
deutlich weniger entzündliche Mediatoren einschließlich IL-1β, TNFα und Osteopontin auf. 
Wird Bleomycin über einen längeren, vierwöchigen Zeitraum injiziert ist die 
Entzündungsreaktion mit der der Kontrolltiere vergleichbar. Möglicherweise spielen dabei 
kompensatorische Mechanismen eine Rolle.  
Zusammenfassend liefert unsere Untersuchung einen Hinweis darauf, dass der TGFβ1 
Signalweg in Makrophagen während der Wundheilung und in der Fibrosebildung 
entzündungsstimulierend und profibrotisch wirkt. 
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1 Introduction 
1.1 Skin: structure and functions 
Skin is a compartmentalized multicellular organ of the body, containing several 
specialized cells and functional structures. It has many functions. The most important 
function is to form a barrier to the environment, allowing and limiting the inward and 
outward passage of water, electrolytes and various substances while providing protection 
against pathogens, UV radiation, toxic agents and mechanical insults. It is composed of 
two primary layers i.e., epidermis and dermis, which interacts anatomically and 
functionally. Epidermis and dermis is separated by a lining of basement membrane. 
Epidermis forms a thin protective layer which is easily regenerated after injury and 
maintains moisture inside the body. Dermis is the thick layer which gives strength to the 
skin and contains blood vessels, nerves and adnexal structures like hair follicles, sweat 
glands, and sebaceous glands.  
         
Fig. 1-1: Schematic organization of the skin and its components (Image courtesy 
Pearson Education Inc.) 
Epidermis 
The epidermis is the most outermost layer of skin, which provides protective functions and 
expresses various proteins. Keratinocytes are the building blocks of epidermis and 
comprise the bulk of this layer (Lee, Jeong et al. 2006). Several inflammatory factors like 
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prostaglandins, eicosanoids, leukotrienes, histamines and cytokines are synthesized and 
secreted from the epidermal keratinocytes, which regulates the immune responses 
(Albanesi, Scarponi et al. 2005). 
                 
Fig. 1-2: Different layers of the epidermis 
The epidermis forms four different layers namely, stratum basale, stratum spinosum, 
stratum granulosum and stratum corneum (Fig. 1-2). The stratum basale layer of the 
epidermis is mainly proliferating keratinocytes, which proliferate and then migrate towards 
outer layer of the skin, which leads to the formation of stratum spinosum. Proliferation and 
migration of keratinocytes are followed by differentiation by increasing cell-cell adhesion 
and modulation of cytoskeletal proteins such as keratins (Tseng, Jarvinen et al. 1982; 
Stoler, Kopan et al. 1988). Immune sentinels like Langerhans cells and other active cells 
derived from bone marrow are found in all epidermis surfaces but are mainly found in 
stratum spinosum layer (Brouard and Barrandon 2003). Further, continuing their transition 
to the cell surface, the cells continue to get flattened and lose their nuclei and their 
cytoplasm appears granular, hence called stratum granulosum. Continuous movement of 
the cells results in formation of subsequent terminal differentiated layer called stratum 
corneum. The stratum corneum consists of hexagonal shaped nonviable cornified cells 
known as corneocytes. In most of the areas of skin there are 30 to 40 layers of stacked 
corneocytes, which are more in palms and soles. Each corneocyte is surrounded by the 
protein envelope and is filled with water retaining keratin proteins. The shape and 
orientation of the keratin proteins adds strength to the stratum corneum. The cornified 
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dead cells are continuously shed off and replaced by underlying cells and this whole 
process contributes to the natural protection of skin against water loss, ultraviolet 
radiation-induced damage as well as environmental and mechanial insults (Smack, Korge 
et al. 1994; Proksch, Brandner et al. 2008). 
Dermis 
The dermis mainly consists of cellular components such as macrophages, mast cells, 
dendritic cells, lymphocytes, fibroblasts, vascular channels and nerves surrounded by and 
embedded in an extracellular matrix network consisting of collagen bundles, elastins, 
fibronectins and proteoglycans. It is mainly 15 to 40 times thicker than epidermis. It 
consists of three layers namely: Papillary layer, subpapillary layer and reticular layer. The 
papillary layer projects into the intervals between the epidermal ridges. The fibre 
components are thin and richly supplied with capillaries, sensory nerve endings and 
cytoplasm. Subpapillary layer is located underlying epidermis and has same components 
as papillary layer. Reticular layer is the largest part of the dermis and consists of dense 
connective tissue composed of fibre components and the lower part of it comes in contact 
with subcutaneous fat layer. The extracellular matrix (ECM) is the largest component of 
the dermis, which provides tensile strength and elasticity to the skin. Collagen fibers 
comprise 70% part of the weight of the dry dermis. The main collagens of the dermis are 
collagen I and collagen III, which provides tensile strength to skin (Dale, Sherratt et al. 
1996). 
1.2 Cutaneous wound healing and cutaneous fibrosis 
Impaired wound healing, defective regeneration as well as fibrosis of diverse tissues are 
leading causes of morbidity and mortality in the aged population. A detailed understanding 
of the complex molecular and cellular events underlying these processes is required to 
design new therapeutic approaches. Repair of damaged tissues after injury is a 
fundamental biological process, proceeding in tightly controlled phases, which are 
significantly affected by age.  
1.2.1 Cutaneous wound healing 
Cutaneous injury is followed by a physiological healing response aiming at the resolution 
of the tissue damage. This is a co-ordinated process of cell activation, migration and 
differentiation, which can be divided into three controlled, regulated and partially 
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overlapping phases namely: inflammation, proliferation and remodeling. Wound healing 
kinetics and the cells involved in the process are shown in Fig. 1-4. 
1.2.1.1 Inflammatory phase 
The inflammatory phase is initiated immediately after tissue damage by local activation of 
the innate immune system. This phase is characterized by the immediate influx of 
polymorphonuclear leukocytes (neutrophils), followed by invasion of blood monocytes 
which differentiate into tissue macrophages.  This early response is generated to mount 
the host response against external injury or microbial invasion. At this stage, tissue 
macrophages and the recruited pool of blood monocytes get activated and act as 
phagocytes for dead cells and damaged cellular components such as tissue debris and 
ECM. The activated cells release several growth factors such as transforming growth 
factor (TGF-β), vascular endothelial growth factor-A (VEGF-A), platelet derived growth 
factors (PDGF), basic fibroblast growth factors (bFGF) etc. to promote the recruitment of 
various cell types, cell proliferation, angiogenesis and production of extracellular matrix 
(Werner and Grose 2003; Eming, Brachvogel et al. 2007). Thus, inflammation is required 
for normal wound healing process. However, an excess of inflammation is associated with 
impaired wound healing (Eming, Krieg et al. 2007), mainly characterized by persistent 
inflammation, excess deposition of ECM and scar formation and lead to the manifestation 
of chronic clinical problems such as formation of keloid, scleroderma and non-healing 
diabetic foot ulcer or venous ulcer (Fig. 1-3). 
          
           Fig. 1-3: Clinical problems of non-healing and over-healing wounds 
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1.2.1.2 Tissue regenerative phase/Proliferative phase 
The early inflammation response is followed by the subsequent regenerative phase. The 
regenerative phase is characterized by transient and limited synthesis and deposition of 
connective tissue, formation of granulation tissue, migration of the keratinocytes (re-
epithelialization), angiogenesis, proliferation and influx of fibroblasts, differentiation of 
fibroblasts into myofibroblasts. The process starts with the accumulation of macrophages 
to mediate diverse functions such as clearance of the dead cells and pathogens, and the 
recruitment and activation of other cell types. The recruited macrophages produce 
chemokines and cytokines, which then activate neighbouring cells such as fibroblasts and 
recruit other immune cells. The activated fibroblasts then undergo differentiation process 
and secrete various growth factors such as TGF-β, CTGF, bFGF and PDGF, which 
regulate proliferation and differentiation of fibroblast as feedback mechanism as well as 
are pre-requisite for the production of extracellular matrix and contraction of wound 
(Garrett, Khaw et al. 2004; Grotendorst and Duncan 2005). Deposition of extracellular 
matrix facilitates cell migration and adhesion. The whole process rebuilds the granulation 
tissue, which consists of collagens and other ECM into which a new network of blood 
vessels start to form under the process called neo-angiogenesis. While granulation tissue 
formation progresses, epithelial cells at the wound margin proliferate to reproduce new 
epithelial cells and grow to close the wound and restore the epidermal barrier function and 
the whole process is called re-epithelialization. At the same time, myofibroblasts present 
at the wound site, which has adhesion properties to ECM, pulls the matrix and minimize 
the wound area to be healed (Hinz 2006). Contraction of smooth muscle actin in 
myofibroblasts leads to contraction of the wound edges and finally myofibroblasts undergo 
apoptosis (Stadelmann, Digenis et al. 1998). This process signals fibroblasts to stop 
migrating and proliferating and also signals onset of the maturation phase of wound 
healing (Greenhalgh 1998). The entire process involves a complex epidermal-
mesenchymal interaction of cells (Werner, Krieg et al. 2007).  
1.2.1.3 Tissue maturation phase 
After restoration of the barrier function, the repair process enters into late phase of 
remodeling. This phase is characterized by scar formation, cell response attenuation and 
apoptosis. In this stage of wound healing, the tissue matures to its final strength which is 
never achieved more than 80% of the pre-injury strength. The major cell types which plays 
role in this phase are macrophages and fibroblasts. The extracellular matrix bound growth 
factors and MMPs are activated by macrophages and fibroblasts, which results in the 
degradation of matrix and differentiation of cells (Streuli 1999). The collagen deposition 
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takes place by active participation of fibroblasts which secretes the collagen in the wound 
tissue area. Collagen is released in the form of pro-collagen, its precursor form. Pro-
collagen is then formed into fibers and arranged in a parallel fashion cross-linked to each 
other forming thicker and stronger strands. There are substantial differences between the 
repaired tissue and non-injured skin. In this phase, the remodeling is achieved by the 
balance between the synthesis of new collagen and the degradation of the old. The 
deposition of newly formed connective tissue is not well anchored to the underlying 
connective tissue matrix and is thicker than the normal skin. The collagens at the wounds 
are reorganized and collagen III gets replaced by collagen I (Braiman-Wiksman, 
Solomonik et al. 2007). Collagen and extracellular matrix deposition continues in the 
wound during this stage. Density of cells like macrophages, keratinocytes, fibroblasts, and 
myofibroblasts is reduced by apoptosis. Firstly, keratinocytes undergo apoptosis followed 
by myofibroblasts. Finally, as the wound healing process gets switched off after going 
through remodeling process, the newly formed connective tissue get matured and the 
colour of the tissue changes from pinkish red to white (Russell 2000). 
 
Fig. 1-4: Schematic representation of wound repair kinetics. 
Wound healing kinetics starts with external injury leading to clot formation and recruitment of 
neutrophils and macrophages during inflammatory phase. After 3-4 days of inflammatory phase, 
keratinocytes proliferate and migrate to close the wound. Tissue formation phase also favors 
myofibroblast differentiation, blood vessels formation and deposition of extracellular matrices, 
followed by tissue maturation phase that results in scar formation (Schafer and Werner 2008). 
1.2.1.4 Importance of the early pro-inflammatory and late anti-inflammatory phase 
for normal wound repair  
During the process of tissue repair, the inflammatory response is dominated by innate 
immune cells such as neutrophils and macrophages while the mid proliferative and late 
remodeling phases are dominated by macrophages and epidermal-mesenchymal cells 
interaction (Werner, Krieg et al. 2007). 
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Although, the inflammatory response is the critical importance for the healing process, it 
has a potential to cause severe tissue damage. Permanent remodeling of the extracellular 
matrix (ECM) due to imbalanced and uncontrolled inflammation, results in increased 
function-impairment, fibrosis and scarring (Fig. 1-5). Keloids and hypertrophic scars are 
the example of skin fibrosis (Bock and Mrowietz 2002; Rahban and Garner 2003). 
Resolution of the inflammatory response is thus essential to terminate the healing process 
and to minimize scar formation. Cell-cell interactions among many different tissue resident 
(e.g. keratinocytes, fibroblasts) and non-resident (hematopoietic) cell types contribute to 
the physiological repair response and are involved in the pathology of repair and fibrosis. 
Hematopoietic cells with a prominent role in local innate immunity such as myeloid cells 
(macrophages and neutrophils) may be of particular importance in controlling the kinetics 
and the balance of pro- and anti-inflammatory signals regulating tissue repair and fibrosis. 
Fibroblasts are the central effectors of repair and fibrotic responses in ECM homeostasis. 
             
 
Fig. 1-5: Outcomes of tissue injury: physiological wound healing or fibrosis. Tissue injury is 
followed by the initiation of blood coagulation cascade which triggers blood clot formation. 
Platelets, which acts as a reservoir of growth factors and cytokines like PDGF and TGF-
β1, degranulates and releases these cytokines which act as chemo-attractant for inflammatory cells 
due to which cells like neutrophils, monocytes and other leukocytes are recruited at the injured site. 
These inflammatory cells secrete several growth factors and cytokines which help in the formation 
and restoration of the injured tissue. If the normal healing process gets uncontrolled, it leads to 
excessive repair process which leads to deposition of excessive ECM in the wound leading to 
fibrosis (Wynn 2007), modified. 
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1.2.2 Cutaneous fibrosis 
Fibrosis is often viewed as a sustained repair response that has escaped control, resulting 
in excessive connective tissue deposition. It is characterized by increased accumulation of 
extracellular matrix, activation of fibroblasts and increased infiltration of immune cells such 
as monocytes/macrophages, mast cells and T-lymphocytes (Roumm, Whiteside et al. 
1984; Kraling, Maul et al. 1995; Yamamoto 2006). The increased amounts of extracellular 
matrix found in the fibrotic tissues are mainly due to an imbalanced collagen remodeling. 
This could either be enhanced collagen synthesis and deposition or impaired collagen 
degradation. Activated and differentiated myofibroblasts are considered as the main 
cellular source of collagen production and deposition in the fibrotic tissue (Hinz 2007). 
Collagen synthesis and degradation is controlled by balance between matrix 
metalloproteinases (MMPs) and their inhibitors, tissue inhibitor of metalloproteinases 
(TIMPs) (Jinnin 2010).  
Fibrotic tissue damage can result from various acute or chronic stimuli, including infection, 
autoimmune reactions, and mechanical injury. Repetitive injection of bleomycin in mice 
has also been shown to induce fibrosis (Yamamoto, Takagawa et al. 1999). In mouse 
models of pulmonary and cutaneous fibrosis, soluble mediators such as chemokines 
(CCL2 & CCL3) (Smith, Strieter et al. 1994; Smith, Strieter et al. 1995; Ferreira, 
Takagawa et al. 2006; Ishida, Kimura et al. 2007) and cytokines (IL-13, IL-33 etc.) 
(Rankin, Mumm et al. 2010) have been shown to contribute fibrosis . Several pro-fibrotic 
factors such as TGF-β and PDGFb, which are involved in the activation, proliferation and 
differentiation of fibroblasts into myofibroblasts, also contribute to the fibrosis 
development. Connective growth factor is another cytokine involved in fibrosis as it 
activates fibroblasts and extracellular matrix production (Frazier, Williams et al. 1996). It is 
induced by TGF-β and acts synergistically downstream to TGF-β in fibrosis induction. 
Moreover, injection of anti-CTGF has been shown to reduce TGF-β1 induced skin fibrosis 
(Chujo, Shirasaki et al. 2005; Ikawa, Ng et al. 2008). In human scleroderma patients, 
increased levels of IL-4, IL-6, IL-13 and TNF-α have been reported previously 
(Needleman, Wigley et al. 1992; Hasegawa, Fujimoto et al. 1997; Hasegawa, Fujimoto et 
al. 1997; Sato, Hasegawa et al. 2001). 
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1.3 Role of macrophages and fibroblasts in tissue repair, fibrosis 
and extracellular matrix production 
Macrophages are considered as a master regulator of the tissue repair process. Studies in 
the 1970s showed that under non-infected conditions, the influx of macrophages was 
essential for efficient healing of incisional wounds in mice (Leibovich and Ross 1975). 
Further studies indicated that the reduced numbers of macrophages at the wound site 
resulted in impaired healing (Werner and Grose 2003; Eming, Krieg et al. 2007; Ishida, 
Gao et al. 2008). Recently, the role of macrophages during different phases of tissue 
repair has clearly been investigated by using the iDTR model under LysMCre promoter 
study (Lucas, Waisman et al. 2010). In the iDTR model Cre-inducible human diphtheria 
toxin receptor transgenic mouse line (iDTR) in which Cre-mediated excision of a STOP 
cassette renders, naturally diphtheria toxin (DT)-resistant mouse cells, DT sensitive. 
However, the exact role of diverse signaling pathway in macrophages during the repair 
process and its impact on the tissue repair has not been described. 
Several chemokines, cytokines, growth factors and fibrotic factors such as CCL2, CCL3, 
GM-CSF, IL-6, IL-1β, TNF-α, TGF-α, FGF, TGF-β, PDGF and VEGF-α are expressed in 
wound tissue (Werner and Grose 2003). Considering that macrophages can produce most 
of the factors, which are modulated during the tissue repair, the role of macrophages 
during this process could be very diverse and could modulate the repair process in 
several ways. Macrophages derived chemokines such as CCL2, CCL3 can favor the 
recruitment of immune cells (Gillitzer and Goebeler 2001) and cytokines such as TNF-α, 
IL-1β and IL-6 can modulate the inflammatory process. TGFβ1 and PDGF are required for 
activation and differentiation of fibroblast into myofibroblasts, which is in turn an essential 
pre-requisite for matrix production and the contraction of collagen matrix (Clark 1993; 
Heldin and Westermark 1999; Schafer and Werner 2008) (Fig. 1-6). The ability of 
macrophages to produce pro-fibrotic factors such as TGFβ1 and PDGF, which can be 
used by fibroblast for activation and production of extracellular matrix, makes them a 
potential candidate for controlling collagen deposition during the repair process. 
Macrophages can also directly impact on extracellular matrix deposition and its turn over 
during tissue repair and fibrosis by secretion of matrix metalloproteinases (MMPs) as well 
as tissue inhibitor of metalloproteinases (TIMPs), which determines the rate of collagen 
turn over (Wynn and Barron 2010). 
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Fig. 1-6: Differentiation of fibroblast into myofibroblast and its function in ECM production 
and wound contraction (Schafer and Werner 2008). 
1.4 TGFβ-TGFβRII signaling 
Transforming growth factor-beta (TGF-β) family comprises many related factors with 
diverse functions such as the regulation of cell growth, differentiation, adhesion, migration 
and apoptosis in a developmental, context-dependent and cell type specific manner. TGF-
β has a profound effect on immune system. It has been implicated in a broad range of 
pathogenic mechanisms where it imparts a primary effect on immune cells. These include 
immune defects, which is associated with autoimmune disease, suppression of immune 
survelliance of tumours, haematopoetic malignancies, susceptibility to parasitic infections 
and chronic inflammatory diseases leading to fibrotic complications. TGF-β was isolated 
from blood platelets (Assoian, Komoriya et al. 1983). It is a homodimer protein of 25 
kDa.There are three homologous TGF-β isoforms present in mammals denoted as TGF-
β1, TGF-β2, TGF-β3 which share 62% to 82% amino acid sequence homology, although 
each is encoded by a separate gene and controlled by a unique promoter. It has been 
examined that all these forms of TGF-β are more than 98% conserved between species. 
TGF-β binds to specific pairs of serine threonine kinase receptor which belongs to a group 
called type I and type II receptors (Massague 1998). The receptor complexes are 
heterotetrameric, consist of two type II receptors (75-80 kDa), which bind to the TGF-β 
ligand and two signal transducing type I receptors (50-60 kDa), which cannot bind the 
ligand directly and considered to act downstream to type II receptors. 
Ligand binding leads to heterodimerization of TGFβRI and TGFβRII. Subsequently, type II 
receptor activates the type I receptor by phosphorylating the GS domain, which is rich in 
glycine and serine residues. The phosphorylated type I receptor phosphorylates the 
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receptor regulated Smads or R-Smads (SMAD-2, SMAD-3), which in turn, phosphorylates 
SMAD4. The complex then moves into the nucleus and directly regulates gene expression 
(Massague 2000) (Fig. 1-7). TGF-β1 has also been reported to induce SMAD-independent 
pathway such as extracellular-signal-regulated kinases (ERK), c-Jun N-terminal kinases 
(JNK) and Phosphoinositide Kinase-3 (PI3K), however the mechanism and functions of 
their activation is still unknown (Derynck and Zhang 2003). 
         
Fig. 1-7: Schematic representation of TGFβ- TGFβRII signaling. 
Dimeric TGFβ binds to TGFβRII that facilitates binding and phosphorylation of TGFβR1. Activated 
TGFβR1 phosphorylates SMAD 2 and 3 proteins, which bind to SMAD4 and together with this 
translocate to the nucleus. In the presence of other co-activators, the SMAD complex bind to the 
target gene and mediate gene expression (Derynck and Zhang 2003). 
TGFβRII exists as a homodimer even in the absence of the ligand (Chen and Derynck 
1994; Henis, Moustakas et al. 1994), however in the absence of TGFβRI, TGFβRII 
homodimers are unable to transduce signal through TGF-β (Luo and Lodish 1996). 
Previous studies have reported that murine TGFβRII has specific binding preference to 
TGF-β1 over TGF-β2, moreover in the tissue which express low levels of TGFβ-1 such as 
cartilage and brain, expression of TGFβRII is either very low or absent (Lawler, Candia et 
al. 1994). 
1.4.1 The role of TGF-β1  and TGF-β1  signaling in tissue repair and fibrosis 
TGF-β1 is a multifunctional cytokine which plays a central role in wound healing and 
fibroplasia (Leask and Abraham 2004). It is of prime importance for the induction but also 
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the resolution of inflammatory responses and stimulates ECM synthesis by fibroblasts. In 
the skin, it is released by infiltrating cells such as lymphocytes, monocytes/macrophages, 
fibroblasts, keratinocytes and platelets. After wounding or inflammation all these cells are 
the potential sources of TGF-β1. The release and action of TGF-β1 stimulates the 
production of the various ECM proteins and inhibits degradation of matrix proteins under 
normal situation, synthesis of the matrix proteins is balanced by the degradation of the 
matrix proteins but, any imbalance in the state of TGF-β1 regulation of matrix deposition 
contributes to tissue fibrosis. Besides organ fibrosis, conditions like hypertrophic scars 
and keloids in skin tissue are caused by TGF-β1. Previous studies showed that the 
amount of TGF-β1 increases in scar deposition and when injected with anti-TGF-β1 and 3 
into the wound margins fibrosis gets reduced (Shah, Foreman et al. 1995). Recently, it 
has been shown that loss of TGF-β1 signaling by targeted deletion of TGFβRII in 
fibroblasts results in impaired repair process (Denton, Khan et al. 2009). 
It is well established that mice with complete deficiency for TGF-β1 die shortly after birth 
due to multi organ inflammation (Shull, Ormsby et al. 1992). TGF-β1 controls pro-
inflammatory and anti-inflammatory responses in immune cells (Letterio and Roberts 
1998). It is also a potent chemotactic cytokine for monocytes (Wahl, Hunt et al. 1987). In 
the context of wound repair and fibroplasia, pro- and anti- inflammatory actions of immune 
cells are the requisite for the normal repair process. In a mouse model, neutralization of 
TGF-β by anti-TGF-β antibody or topical application of peptide inhibitor of TGF-β has been 
shown to improve bleomycin-induced skin fibrosis (Yamamoto, Takagawa et al. 1999; 
Santiago, Gutierrez-Canas et al. 2005). Mice lacking TGFβRII is embryonic lethal with 
defective yolk sac vasculogenesis (Oshima, Oshima et al. 1996) and therefore its role in 
cutaneous wound healing or fibrosis is not well understood. Currently, it is unresolved that 
whether TGF-β1 directly controls the function of immune cells through TGFβRII during 
skin repair process and fibrosis.       
1.4.2 The role of TGFβ1-TGFβRII mediated functions in macrophages  
Macrophages are known for their classical roles in phagocytosis and as antigen 
presenting cells. In its plethora of functions, gradually its role in maintaining tissue 
homeostasis and mediating inflammatory and immune responses is gaining recognition 
from the findings in recent years (Lucas, Waisman et al. 2010). TGF-β1 is one of the 
cytokines known to secreted by macrophages and in turn known to modulate responses, 
such as monocyte activation, proliferation, cytokine production, host defense and 
chemotaxis (Strassmann, Cole et al. 1988; Ashcroft 1999). Studies have implicated that 
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TGF-β1 plays a bidirectional role on macrophage functions and acts as potent 
immunosuppressive as well as activating factor (Tsunawaki, Sporn et al. 1988; Ashcroft 
1999). The action of TGF-β1 on monocytes/macrophages is dependent on the state of 
cellular differentiation, cytokine milieu and the concentration gradient of TGF-β1 itself 
(McCartney-Francis and Wahl 1994; Wahl 1994). Monocytes are known to express TGF-
β1 mRNA constitutively but the mRNA and protein levels do not necessarily correlate 
(Assoian, Fleurdelys et al. 1987; McCartney-Francis, Mizel et al. 1990). Activated 
monocytes and macrophages secrete increased levels of TGF-β1. Monocytes and 
macrophages are also known to regulate the expression of TGF-β1 in autocrine and 
paracrine manner (Wahl, McCartney-Francis et al. 1990). At the site of injury, the platelets 
degranulate and release a concentrated amount of TGF-β1, which acts as a 
chemoattractant for the inflammatory cells. TGF-β1 favors recruitment of monocytes in 
vitro in femtomolar concentration (Wahl, Hunt et al. 1987; Wiseman, Polverini et al. 1988). 
It has been shown that intradermal or intra-articular injection of TGF-β1 stimulates 
recruitment of monocytes and macrophages and matrix deposition. TGF-β1 mediates 
monocyte production of cytokines, which acts as additional mononuclear cells 
chemoattractant (Luger, Charon et al. 1983). Resting monocytes, which are stimulated by 
picomolar concentration of TGF-β1 responds by up-regulating TGF-β1 transcription and 
secretion in an autocrine feedback loop (Wahl, McCartney-Francis et al. 1990). After 
injury, the inflammatory cells, like monocytes have to get recruited at the injury site and for 
that they need to transverse the endothelial basement membrane. TGF-β enhances the 
expression of integrins like LFA-1, which binds to ICAM-1 and α3β1 receptors required to 
mediate the monocyte binding to fibronectin, laminin and collagen (Bauvois, Rouillard et 
al. 1992; Wahl, Allen et al. 1993). TGF-β1 also enhances the expression of fibronectin 
receptor α5β1, which enhances the attachment of monocytes to the provisional matrix 
deposited at the sites of cutaneous wounds (Wahl, Allen et al. 1993). It has been shown 
that picomolar concentration of TGF-β1 stimulates monocytes to transcribe a variety of 
cytokines such as TNF-α, PDGF, b-FGF, IL-6, VEGF and IL-1 which in turn modulates cell 
function (Wiseman, Polverini et al. 1988; McCartney-Francis, Mizel et al. 1990; Jeon, 
Chae et al. 2007). Therefore, in the cells, which express TGFβRII including macrophages, 
TGF-β1 can stimulate its own production and the production of the various pro-
inflammatory factors, pro-fibrotic and pro-angiogenic factors, ECM proteins, matrix 
metalloproteinases and tissue inhibitor of metalloproteinases, thus can modulate quality of 
tissue repair and fibrosis (Fig. 1-8).  
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Fig. 1-8: Schematic representation of TGF-β1  mediated functions in macrophages, 
modulating the outcome of tissue repair and fibrosis.  
During tissue repair and fibrosis, TGF-β1 can be secreted from various sources and act on 
TGFβRII expressing cells. Binding of TGF-β1 to TGFβRII on macrophages induces auto-induction 
of TGF-β1, which can modulate macrophage function either by autocrine interaction on 
macrophages or by paracrine interaction on different cell types such as endothelial cells, 
keratinocytes and fibroblasts. Both autocrine and paracrine interaction of TGF-β1 can lead to the 
production of other factors such as VEGF, IL-1β, IL-6, TNF-α, MMPs, thus the cells are further 
modulated to generate tissue repair response or fibrotic response.  
TGF-β1 is also known to induce the expression of Fc gamma receptor III (FcγRIII), which 
in turn enhances the phagocytotic capacity of macrophages (Welch, Wong et al. 1990). 
The potent proinflammatory effect of TGF-β1 has been shown in vivo by using its 
antagonist, where the local inflammatory effect of TGF-β1 got diminished after treatment. 
By administration of anti-TGF-β1 antibody locally in the tissue it has been shown that the 
fibrosis and the influx of inflammatory cells gets reduced which also indicates that 
inflammatory cells and TGF-β1 expressed by those cells have a profound effect on tissue 
fibrosis and scar formation. 
Besides pro-inflammatory action, TGF-β1 also acts as anti-inflammatory cytokine in 
modulating macrophage functions. At the site of injury, during the maturation process of 
monocytes into macrophages, the expression of TGF-β receptor gets down-regulated, 
which leads to a decline sensitivity of the macrophages towards TGF-β1 response. 
Furthermore, due to this change the same TGF-β1, which initially acted as a pro-
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inflammatory factor, starts acting as anti-inflammatory cytokine and helps in the resolution 
of the inflammation. In vitro, TGF-β inhibits the LPS mediated up-regulation of MIP-1α and 
MCP-1, which are potent chemoattractant expressed by macrophages (Ashcroft 1999; Li, 
Wan et al. 2006). Phagocytotic macrophages tend to phagocytose neutrophils and 
express more TGF-β in the resoluting tissue. This enhanced expression of TGF-β in the 
local milieu leads to down-regulation of inflammatory cytokines like GM-CSF, TNF-α and 
IL-8 (Fadok, Bratton et al. 1998). Immunosuppressive effect of TGF-β on macrophages 
has been reported under in vivo condition such as streptococcal cell wall induced arthritis, 
allergic encephalomyelitis (Brandes, Allen et al. 1991; Kuruvilla, Shah et al. 1991; Racke, 
Dhib-Jalbut et al. 1991). 
1.5 Cre-LoxP system and LysMCre mouse strain  
Cyclization recombinase-LoxP (Cre-LoxP) is based on site-specific in vivo recombination 
of LoxP sites and allows successful genetic manipulation of the target genes (Araki, 
Imaizumi et al. 1997). The system requires insertion of 34 base pair nucleotides named as 
Lox P site in a way that it flanks the exons to be deleted in the target gene. The sequence 
consists of two flanking 13 bp inverted repeats and an 8 bp core sequence: 
ATAACTTCGTATA - GCATACAT –TATACGAAGTTAT.  
 Cre is the tyrosin recombinase enzyme derived from P1 bacteriophage (Abremski and 
Hoess 1984; Hamilton and Abremski 1984), which carries out site specific recombination 
between two loxP sites (Nagy 2000). LysM promoter is expressed in myeloid cell lineage 
and therefore expression of Cre recombinase under the control of LysM promoter 
efficiently targets the loxP flanked gene of interests in monocytes, mature macrophages 
and neutrophils (Clausen, Burkhardt et al. 1999). 
Myeloid cell specific TGFβRII mutant mice were generated using LysMCre-loxP DNA 
recombination system. Mice carrying flanked loxP sites on exon 3 of the TGFβRII alleles 
(Cazac and Roes 2000) were crossed with the transgenic mice that express Cre 
recombinase under the control of the endogenous Lysozyme M (LysM) promoter 
(Clausen, Burkhardt et al. 1999). Myeloid cells, which express Cre recombinase are able 
to perform recombination of the flanked loxP sites in the alleles and truncation of the 
TGFβRII protein expression. 
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2 Aims 
The role of TGF-β in wound repair and fibrosis has been well described. TGF-β is 
secreted by and acts on all cell types. TGF-β produced at the site of injury or fibrosis acts 
on diverse cell types that expresses its receptor TGFβRII. A complex network of soluble 
factors and cell-cell interaction controls the wound healing and fibrosis and therefore it is 
still unclear how a cell type-specific interaction of TGF-β and its receptor, TGFβRII 
modulates the tissue response.   
Macrophages are one of important cell types, which help in the healing process. 
Additionaly, they are the one of the important sources of TGF-β1. Although, macrophages 
are actively involved in the repair process, specific contribution of TGFβ1-TGFβRII 
signaling pathway in macrophages has not been studied so far. Therefore, in this study, 
we specifically intend to clarify the role of  TGFβRII on macrophages in regulating the 
connective tissue response to mechanical and inflammation-mediated tissue damage in 
skin.  
To address this, the aims are as following: 
1. Generation of myeloid cell specific TGFβRII deficient mice 
2. Analysis of the consequences of TGFβRII gene deletion in macrophages with respect 
to the quality and kinetics of skin repair and fibrosis in response to mechanical injury 
3. Analysis of the functional impact of TGFβRII in macrophages in regulating skin fibrosis 
in response to inflammatory tissue damage 
4. To study which specific cell functions in tissue repair and fibrosis are controlled by 
TGFβRII mediated activation of myeloid cells  
5. Identification of the mechanisms and mediators, which are responsible for the obtained 
phenotype 
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3 Results 
3.1 Generation of myeloid cell specific TGFβRII deficient mice  
To elucidate the impact of TGF-β1 mediated functions of myeloid cells during skin repair 
process and fibrosis, mice were generated, in which, TGFβRII can be specifically 
abrogated in myeloid cell population. The myeloid cell specific TGFβRII deficient mouse 
was generated by crossing the mouse line carrying the TGFβRII gene, flanked by loxP 
sites (provided by Jürgen Roes, University College London) (Cazac and Roes 2000) with 
a mouse line expressing Cre recombinase under the control of the LysM (Lysozyme M) 
promoter (provided by Irmgard Förster, University Düsseldorf (Clausen, Burkhardt et al. 
1999). This system allows the expression of myeloid cell specific Cre recombinase and 
thereby the deletion of the loxP flanked exon (exon 3) of TGFβRII gene, specifically in the 
myeloid cells. Excision of exon 3 from the TGFβRII gene resulted in premature termination 
and truncation of TGFβRII protein synthesis, specifically in myeloid cells.  
3.1.1 Myeloid cell specific deletion of TGFβRII  
The presence of the floxed allele and transgenic LysMCre promoter was confirmed by 
genotyping PCR obtained from mouse tail biopsies. The resulting PCR product showed a 
band of 550 bp for the TGFβRII floxed allele, a band of 500 bp for the TGFβRII wildtype 
allele, 700 bp for LysMCre and 350 bp for the LysM wildtype allele (Fig. 3-1A). To confirm 
myeloid cell specific disruption of the TGFβRII gene particularly in macrophages, a 
Southern blot on genomic DNA and Western blot on the cultured peritoneal macrophages 
was performed. 
Southern blot analysis was performed on the genomic DNA of FACS sorted, F4/80
+
 
peritoneal macrophages, isolated from peritoneal cavity of wild type control mice 
(TGFβRII
wt/wt
), floxed control mice (TGFβRII
fl/fl
) and from mice lacking TGFβRII in 
macrophages (TGFβRIIfl/flLysMCre). NcoI digested genomic DNA resolved on gel was 
probed with a source specific for exon 2. As revealed on the blot (Fig. 3-1C), the NcoI 
digested DNA from wild type control macrophage (TGFβRII
wt/wt
) showed a band of 2.7 kb. 
NcoI digested DNA from TGFβRII floxed control macrophages (TGFβRII
fl/fl
LysMCre) 
showed a slightly larger band of 2.9 kb. The digested DNA from TGFβRII
fl/fl
LysMCre 
macrophages also shows a faint band of 2.9 kb and an additional band of 1.8 kb 
corresponding to the TGFβRII gene with the deleted exon 3. Densitometric analysis of the 
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1.8 kb band obtained from genomic DNA of TGFβRIIfl/flLysMCre macrophages indicated 
that approximately 80% of TGFβRII were truncated (Fig. 3-1C), thus confirming an 
efficient deletion at genomic level. 
To confirm the deletion of TGFβRII on the protein level, peritoneal macrophages from 
control and TGFβRIIfl/flLysMCre mice were isolated, cultured and analyzed for TGFβRII 
expression by western blot. In Control macrophages, specific antibody against TGFβRII, 
detected a band of approximately 70 kDa, whereas TGFβRIIfl/flLysMCre macrophages 
showed loss of this band (Fig. 3-1D), which further confirms an efficient truncation of the 
TGFβRII expression in macrophages. 
 
Fig. 3-1: Macrophage specific deletion of TGFβRII 
A) Schematic diagram and amplicons of the mouse tail genotyping PCR. Genotyping PCR from 
mouse tail DNA showed 550 bp band size in TGFβRIIfl/fl mouse, whereas TGFβRIIfl/+ mouse 
showed 550 bp band of floxed allele as well as 500 bp of wild type allele (upper panel). Genotyping 
PCR of LysMCre showed a band of 700 bp and a wild type of 350 bp (lower panel). B) Schematic 
diagram of exons of TGFβRII gene, floxed exon and the deleted exon of TGFβRII after Cre 
recombinase activity detected by southern blot. C) Southern blot analysis of genomic DNA 
obtained from FACS sorted control and TGFβRIIfl/flLysMCre peritoneal macrophages. The NcoI 
digested DNA showed a band of 2.7 kb in TGFβRIIwt/wt control, a floxed band of 2.9 kb in floxed 
TGFβRIIfl/fl control without Cre whereas, the digested DNA from TGFβRIIfl/flLysMCre showed one 
band of 2.9 kb (floxed) and another band of 1.8 kb (deleted). Densitometric analysis revealed 
approximately 80% deletion of the floxed band in TGFβRIIfl/flLysMCre mice. D) Western blot 
analysis of TGFβRII expression in cultured peritoneal macrophages showed presence of 70 kDa 
protein of TGFβRII in control macrophages and abscence in TGFβRIIfl/flLysMCre macrophages. 
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3.1.2 Loss of TGFβ1−TGFβRII signaling in TGFβRII
fl/fl
LysMCre macrophages 
TGFβRII binds to TGFβ1, which results in the recruitment of TGFβRI and phosphorylation 
of cytosolic signal transducers Smad2 and Smad3 (Massague 2000). To confirm the 
functional impairment of TGFβ1 mediated downstream signaling in TGFβRIIfl/flLysMCre 
macrophages, peritoneal macrophages from control and TGFβRIIfl/flLysMCre mice were 
isolated, cultured and stimulated with 20ng/ml recombinant TGF-β1 (rTGF-β1) for 10 and 
30 minutes. The Smad2 phosphorylation was used as a read out and its expression was 
analyzed by Western blot in stimulated and un-stimulated cells. Macrophages from control 
mice showed strong phosphorylation of Smad2 after 10 and 30 minutes of rTGF-β1 
stimulation, however macrophages from TGFβRIIfl/flLysMCre mice did not show 
phosphorylation of Smad2 at any time point investigated, indicating impaired TGF-β1 
mediated downstream signaling in TGFβRIIfl/flLysMCre macrophages (Fig. 3-2). 
                                                          
 
Fig. 3-2: Loss of TGFβ1-TGFβRII signaling in TGFβRIIfl/flLysMCre macrophages. Western blot 
analysis of lysates from peritoneal macrophages isolated from control and TGFβRIIfl/flLysMCre 
mice, stimulated with rTGF-β1 (20ng/ml) for 10’ and 30’ minutes showed TGF-β1 mediated 
activation of Smad2 in control macrophages and no phosphorylation of Smad2 in TGFβ 
RIIfl/flLysMCre macrophages. Total Smad2 protein served as a loading control. pSmad2: phospho 
Smad2. 
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3.2 Effect of TGFβRII deletion in myeloid cells on thioglycollate 
induced peritonitis and in vitro macrophage chemotaxis 
3.2.1 Abolishment of anti-inflammatory effect in TGFβRIIfl/flLysMCre mice 
during an inflammatory model of thioglycollate induced peritonitis 
Transforming growth factor beta (TGF-β) is a multifunctional cytokine, whose myriad of 
functions include the potent suppression of the immune system and the recruitment of 
monocytes in vitro (Li, Wan et al. 2006). After assuring the successful deletion of TGFβRII 
in myeloid cells, the role of TGFβRII was analyzed in a model of  thioglycollate induced 
peritonitis on infiltration of leukocyes. Thioglycollate was injected into the peritoneum 
cavity of control and TGFβRIIfl/flLysMCre mice and after 4 days, peritoneal cells were 
harvested and counted under the microscope using haemocytometer chamber slide. This 
analysis showed an increase of total leukocyte cell numbers in peritoneal lavage of 
TGFβRIIfl/flLysMCre mice compared to control mice, indicating an enhanced inflammatory 
condition in the peritoneum that might be generated due to the loss of anti-inflammatory 
effect of TGF-β on myeloid cells (Fig. 3-3). 
 
Fig. 3-3: Enhanced leukocyte recruitment in thioglycollate induced peritonitis model due to 
the loss of TGFβRII in myeloid cells. Peritoneal leukocytes isolated after thioglycollate injection 
showed an increase in total number in TGFβRIIfl/flLysMCre mice compared to control mice. 
Statistical significance was determined using student’s t-test test. PL: Peritoneal lavage. 
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Enhanced leukocyte recruitment in thioglycollate induced peritonitis in TGFβRIIfl/flLysMCre 
mice raised the question whether the deletion of TGFβRII in myeloid cells directly 
influences their migration in thioglycollate induced peritonitis.  
To address the question, peritoneal cells were isolated from control and 
TGFβRIIfl/flLysMCre mice after four days of thioglycollate injection and analyzed by flow 
cytometry. However, a similar percentage of CD11b+/F480+ and CD115+/F4/80+ 
monocytes as well as CD11b+/Gr-1+ neutrophils were observed in both the mice (Fig. 3-4). 
                   
    
Fig. 3-4: Similar fractions of monocytes/macrophages and neutrophils in thioglycollate 
induced peritonitis. FACS analysis and quantification of peritoneal cells after 4 days of 
thioglycollate injection showed similar percentage of CD11b+/F480+ macrophages (A), 
CD115+/F4/80+ monocytes (B) and CD11b+/Gr-1+ neutrophils (C). Horizontal lines represent the 
mean of independent experiments. Statistical significance was determined using student’s t-test. 
3.2.2 Impact of TGFβRII deficiency on in vitro random migration of 
macrophages 
To address the question whether the deletion of TGFβRII also impacts in vitro migration, 
peritoneal macrophages were isolated from control and TGFβRIIfl/flLysMCre mice, cultured 
in DMEM medium supplemented with either 1% or 10% of fetal calf serum (FCS). The 
random migration was determined using Olympus 1X81 microscope under humidified 
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chamber supplied with 5% CO2. Interestingly, in the medium supplemented with 1% FCS, 
migration of TGFβRIIfl/flLysMCre macrophages was significantly reduced compared to 
control macrophages, whereas in the medium supplemented with 10% FCS, similar 
migration of TGFβRII
fl/fl
LysMCre and control macrophages was observed (Fig. 3-5). 
              
Fig. 3-5: Random migration of peritoneal macrophages. 
Random migration of peritoneal macrophages in the medium supplemented with 1% FCS was 
reduced in TGFβRIIfl/flLysMCre macrophages, whereas in 10% FCS supplemented medium, both 
control and TGFβRIIfl/flLysMCre macrophages showed similar random migration. Horizontal lines 
represent the mean of independent experiments. Statistical significance was determined using 
student’s t-test. 
3.3 Impact of TGFβRII deficiency in macrophages on the repair 
process 
3.3.1 TGFβRII deficiency does not impair kinetics of wound closure but 
delays wound contraction 
To investigate the consequences of TGFβRII deficiency in macrophages with respect to 
the quality and kinetics of skin repair in response to mechanical tissue injury, a 6 mm full 
thickness wounds were created on the back of control and TGFβRII
fl/fl
LysMCre mice. 
Healing kinetics and microscopic assessment of various wound healing parameters on 
day 4, day 7 and day 14 post injury were performed. An overview of wound healing 
parameters investigated is shown in Fig. 3-6A. 
The full thickness wounds on control and TGFβRIIfl/flLysMCre mice healed almost with the 
similar kinetics. Macroscopic observation was further confirmed by histological 
investigation of H&E stained wound sections, which showed no obvious difference in the 
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wound closure between control and TGFβRIIfl/flLysMCre mice at day 4, day 7 and day 14 
post injury (Fig. 3-6B). For histological quantification, the amount of granulation tissue, the 
distance between the ends of epithelial tips and the length of the epithelial tongue and 
distance between the ends of the panniculus carnosus were measured on H&E stained 
paraffin sections. The amount of granulation tissue, the distance between the two ends of 
the epithelial tips and the epithelial tongue (re-epithelialization) at day 4, day 7 and day 14 
post injury were similar in both control and TGFβRIIfl/flLysMCre wounds (Fig. 3-6C).  By 
contrast, TGFβRIIfl/flLysMCre wounds showed delayed wound contraction, when the 
distance between the wound edges i.e., panniculus carnosus was measured 
microscopically. The distance between panniculus carnosus was significantly reduced in 
TGFβRIIfl/flLysMCre wounds compared to control wounds at day 4 post injury and day 7 
post injury (Fig. 3-6D). This result indicates that the loss of TGF-β1 mediated response in 
the TGFβRIIfl/flLysMCre macrophages results in delayed wound contraction. 
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Fig. 3-6: Loss of TGFβRII on macrophages does not impact overall wound repair kinetics, 
epithelialization, granulation tissue formation but attenuates wound contraction. 
A) H&E staining of wound section from day 7 post injury showing general wound parameters  (g: 
granulation tissue) B) H&E staining of wound sections from control and TGFβRIIfl/flLysMCre mice at 
day 4, day 7 and day 14 post injury showed no microscopic difference in the healing kinetics. C) 
Microscopic measurement of distance between epithelial tips and epithelial tongue, and the amount 
of granulation tissue shows no difference at day 4, day 7 and day 14 post injury between control 
and TGFβRIIfl/flLysMCre wounds. D) Distance between the edges of the panniculus carnosus at 
day 4 and day 7 post injury revealed a significantly attenuated wound contraction in 
TGFβRIIfl/flLysMCre wounds compared to control wounds. Horizontal lines represent the mean. 
Statistical significance was determined using student’s t-test. 
3.3.2 Impaired myofibroblast differentiation and impaired deposition of 
collagen at the wound site of TGFβRIIfl/flLysMCre mice  
Differentiation of fibroblasts into myofibroblast concomitant with the acquisition of 
contractile features is essential for connective tissue remodelling and wound contraction 
during normal and pathological wound healing (Hinz 2007).	  To analyze whether delayed 
wound contraction	   in	   TGFβRIIfl/flLysMCre mice was due to impaired myofibroblast 
differentiation, the presence of myofibroblast in wounds was investigated at day 4, day 7 
and day 14 post injury. Wound tissues were stained for alpha smooth muscle actin (α-
SMA), which is a marker for the activated fibroblast/myofibroblast (Darby, Skalli et al. 
1990). The staining revealed, reduced expression of α-SMA in granulation tissue of 
TGFβRIIfl/flLysMCre wounds compared to control wounds at day 7 post injury (Fig. 3-7A). 
Quantification of α-SMA positive area in total granulation tissue further confirmed, a 
significant reduction in TGFβRIIfl/flLysMCre wounds compared to control wounds at day 7 
B	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post injury, (Fig. 3-7B). This analysis suggested that myofibroblast differentiation in 
TGFβRIIfl/flLysMCre wounds is impaired. 
 
Fig. 3-7: Altered myofibroblast differentiation in TGFβRIIfl/flLysMCre wound tissue. A) 
Immunofluorescense staining and B) quantification of the α-SMA positive area, at day 4, day 7 and 
day 14 post injury within the granulation tissue showed significant reduction of expression in  
TGFβRIIfl/flLysMCre compared to control wounds at day 7 post injury. Statistical significance was 
determined using student’s t-test. Horizontal lines represent the mean. e; epidermis, g; granulation 
tissue.	  
One of the essential functions of myofibroblast is the production of collagen (Gabbiani 
2003). Since, TGFβRIIfl/flLysMCre wounds showed reduced α-SMA positive area, the 
question was whether this leads to the functional impairment of myofibroblasts. To 
address this question, collagen bundles were analyzed in the wounds. Wound sections 
from day 14 post injury were stained with Sirius red, which binds to collagens and can be 
visualized by polarized microscope. This analysis revealed an attenuated collagen 
deposition in TGFβRIIfl/flLysMCre wounds compared to control wounds (Fig. 3-8).  
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Fig. 3-8: Attenuated collagen deposition in TGFβRIIfl/flLysMCre wound. Sirius red staining on 
control and	  TGFβRIIfl/flLysMCre	  wound at day 14 post injury showed attenuated collagen deposition 
in TGFβRIIfl/flLysMCre wound compared to control wound (n= 3-4) at 20x and higher 40x 
magnification.	  
Connective tissue growth factor (CTGF) is one of the important factors, produced by 
activated myofibroblast and required for myofibroblast proliferation and differentiation 
(Grotendorst and Duncan 2005). Moreover, TGF-β1 activated CTGF expression in 
fibroblast has been shown to be important for myofibroblast differentiation (Garrett, Khaw 
et al. 2004). To address the question whether myofibroblast function was also affected at 
the molecular level in TGFβRIIfl/flLysMCre wounds, expression of connective tissue growth 
factor (CTGF) was analyzed on RNA isolated from wound tissue at day 4, day 7 post 
injury by quantitative real time PCR. Expression of CTGF in TGFβRIIfl/flLysMCre wounds 
at day 4 post injury showed reduction compared to control wounds, however at later 
stages of the healing, CTGF expression was similar to the level in control wounds (Fig. 3-
9). This analysis supports the hypothesis that the deficiency of TGFβRII signaling in the 
macrophages results in impaired fibroblasts-macrophage interaction, thereby affecting 
transition of fibroblast to myofibroblast and myofibroblast functions.  
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Fig. 3-9: Reduced expression of CTGF in TGFβRIIfl/flLysMCre wounds. Real time PCR analysis 
of total wound tissue at day 4 and day 7  post injury showed no up-regulation of CTGF in 
TGFβRIIfl/flLysMCre wounds at day 4 post injury compared to the up-regulation in control wounds. 
Expression in wounded skin of control and TGFβRIIfl/flLysMCre mice and unwounded skin of 
TGFβRIIfl/flLysMCre mice is normalized over control unwounded skin. Horizontal lines represent the 
mean. Statistical significance was determined using student’s t-test. NS: unwounded normal skin, 
W: wound tissue.	  
Reduced wound contraction and myofibroblast differentiation, accompanied by impaired 
CTGF and altered collagen deposition at the wound site, posed the question of why this 
was so. Based on the previous known role of TGF-β1 on macrophages and fibroblasts, 
two hypotheses can be proposed:  
1. TGF-β1 regulates its own production in macrophages in an autocrine manner (Wahl, 
McCartney-Francis et al. 1990; Lucas, Waisman et al. 2010). Due to the deficiency of 
TGFβRII, its autocrine regulation might be impaired in macrophages, thereby less TGF-β1 
is available to wound fibroblasts to proliferate and differentiate into myofibroblast. 
Moreover, TGF-β1 is a direct regulator of CTGF production from fibroblast (Garrett, Khaw 
et al. 2004), thereby the reduced availability of TGF-β1 can also affect CTGF and collagen 
production from the activated fibroblasts in the wounds of TGFβRIIfl/flLysMCre mice. This 
will lead to the delayed wound contraction.  
2. Besides autocrine TGF-β1 regulation, TGFβRII mediated signaling in macrophages also 
regulate production of fibronectin, osteopontin, platelet derived growth factors, tissue 
plasminogen activator etc, which are in turn, also required for differentiation of fibroblasts 
into myofibroblasts and their functions (McCartney-Francis, Mizel et al. 1990; Lenga, Koh 
et al. 2008; Schafer and Werner 2008). Therefore, macrophage-derived factors under 
TGFβRII mediated signaling also mediate cross talk between macrophage and fibroblast, 
which could be disturbed due to the loss of TGFβRII signaling in macrophages.  
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3.3.3 Similar expression of TGF-β1  in the wounds of control and 
TGFβRIIfl/flLysMCre mice  
To address the possibility that TGFβRIIfl/flLysMCre wounds may have less availability of 
TGF-β1 due to an impaired autocrine loop, the expression of TGF-β1 was analyzed on 
RNA isolated from control and TGFβRIIfl/flLysMCre wounds at day 4 and day 7 post injury 
by quantitative real time PCR. This analysis showed up-regulation of TGF-β1 in both 
control and TGFβRIIfl/flLysMCre wounds at day 7 post injury compared to normal skin, 
however no significant differential regulation in TGF-β1 expression was observed between 
control and TGFβRIIfl/flLysMCre wounds (Fig. 3-10). This result indicates that possibly a 
different mechanism is involved to mediate cross talk between macrophages and 
fibroblasts. 
                         
Fig. 3-10: Similar expression of TGF-β1  in control and TGFβRIIfl/flLysMCre wound tissues. 
Real time PCR analysis of total wound tissue at day 4 and day 7 post injury showed no difference 
in TGF-β1 expression between control and TGFβRIIfl/flLysMCre wounds. Expression in wounded 
skin of control and TGFβRIIfl/flLysMCre mice and unwounded skin of TGFβRIIfl/flLysMCre is 
normalized over control unwounded skin. Horizontal lines represent the mean. Statistical 
significance was determined using student’s t-test. NS: unwounded normal skin, W: wound tissue	  
3.3.4 Loss of TGFβRII in macrophages does not impact neo-angiogenesis 
TGF-β1 is a regulator of angiogenesis and also induces angiogenic activity in 
macrophages (Wiseman, Polverini et al. 1988). To assess the impact of TGFβRII 
deficiency in macrophages on angiogenesis, endothelial cells in the granulation area of 
wound tissue were quantified. Immunofluorescence staining (Fig. 3-7A; shown in the 
section 3.3.2) and quantification of CD31 positive cells in control and TGFβRIIfl/flLysMCre 
wounds did not show any significant difference at day 4, day 7 and day 14 post injury (Fig. 
3-11A). VEGF−A is a crucial regulator of angiogenesis and its expression in macrophages 
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is induced by TGF-β1 (Jeon, Chae et al. 2007). To address the question whether 
expression of VEGF-A is affected due to the deficiency of TGFβRII signaling in 
macrophages, its expression was analyzed in control and TGFβRIIfl/flLysMCre wounds at 
day 4 and day 7 post injury by real time PCR. However, similar expression levels of 
VEGF-A was found in control and TGFβRIIfl/flLysMCre wounds and correlated with the 
similar angiogenesis response observed in wounds from both genotypes (Fig. 3-11B).  
 
Fig. 3-11: Loss of TGFβRII in macrophages does not impact angiogenesis. A) Quantification 
of CD31 positive endothelial cells within the granulation tissue at day 4, day 7 and day 14 post 
injury showed no significant difference between control and TGFβRIIfl/flLysMCre wounds. B) Real 
time PCR analysis of VEGF-A expression in wound tissue at day 4 and day 7 post injury showed 
no difference in regulation between control and TGFβRIIfl/flLysMCre mice. Expression in wounded 
skin of control and TGFβRIIfl/flLysMCre mice and unwounded skin of TGFβRIIfl/flLysMCre mice was 
normalized over control unwounded skin. Horizontal lines represent the mean. Statistical 
significance was determined using student’s t-test. NS: unwounded normal skin, W: wound tissue. 
3.3.5 Loss of TGFβRII in macrophages does not impact infiltration of 
macrophage into the wound site  
TGF-β1 is one of the most potent chemo-attractants for monocytes (Wahl, Hunt et al. 
1987) and recruitment of monocytes and macrophages is an essential requirement for the 
normal healing process as previously shown by depletion of macrophages from the wound 
site (Lucas, Waisman et al. 2010). However, the role of TGFβ1-TGFβRII signaling in 
monocyte recruitment during the repair process has not been described very well.  
To analyze the impact of TGFβRII deficiency in macrophage on the recruitment to the 
wound site, cells were analyzed by immunostaining of wound sections and quantified by 
flow cytometry. Surprisingly, in immunofluorescence stainings, the number of F4/80 
positive macrophages seemed to be similar between control and TGFβRIIfl/flLysMCre 
wounds at day 4 and day 7 post injury (Fig. 3-12A). Quantification of CD11b/F4/80 
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positive cells and CD11b/Gr-1 positive cells was performed by FACS analysis on the cells 
isolated from control and TGFβRIIfl/flLysMCre wound tissue. This analysis revealed two 
different CD11b+/F4/80+ populations with high and low intensity of F4/80 staining, 
respectively (Fig. 3-12B). However, no significant difference was observed in the 
percentage of both cell population in control and TGFβRIIfl/flLysMCre wounds, which was 
consistent with the immunostaining (Fig. 3-12B & C). Similar to CD11b/F4/80 positive 
macophages, no significant difference was observed in CD11b/Gr-1 positive neutrophils 
between control and TGFβRIIfl/flLysMCre wounds (Fig. 3-12D). This result also correlates 
with the similar recruitment of monocytes to the peritoneal cavity in thioglycollate-induced 
peritonitis in control and TGFβRIIfl/flLysMCre mice (shown in the section 3.2.2). This 
indicates the involvement of other potent factors in the recruitment of monocytes under in 
vivo inflammation. 
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Fig. 3-12: TGFβRII deficiency in macrophages does not alter recruitment of cells to the 
wound site. A) Immunofluorescence staining and quantification of F4/80 positive cells in wounds 
showed similar numbers of F4/80 positive macrophages between control (n= 2) and 
TGFβRIIfl/flLysMCre (n=3) mice. B, C, D) FACS analysis quantification of macrophages (B, C)  and 
neutrophils (D), isolated from control and TGFβRIIfl/flLysMCre wounds at day 4, day 7 and day 14 
post injury revealed no difference in the percentage of macrophages and neutrophils population. 
Horizontal line represents the mean. Statistical significance was determined using student’s t-test. 
NS: unwounded normal skin, W: wound tissue. HPF: high power field. NS: unwounded normal skin, 
W: wound tissue. HPF: high power field 
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3.3.6 Loss of TGFβRII in macrophages has no influence on inflammatory 
cytokine induction 
To analyze the impact of loss of	   TGF-β1 signaling on the regulation of the local 
inflammatory cytokine milieu in wound tissue, expression of TNF-α and IL-1β was 
analyzed at day 4 and day 7 post injury by real time PCR. TNF-α and IL-1β are the crucial 
cytokines, up-regulated during the  inflammatory phase of wound healing. As expected, 
both the cytokines were highly up-regulated in wound tissue at day 4 post injury while their 
expression declined by day 7 post injury. However, no significant difference in the 
regulation was observed between control and TGFβRIIfl/flLysMCre wounds (Fig. 3-13).	  
 
Fig. 3-13: Similar expression of TNF-α  and IL-1β  in control and TGFβRIIfl/flLysMCre wound 
tissue. Real time PCR analysis of total wound tissue at day 4 and day 7 post injury indicated 
similar level of up-regulation of TNF-α and IL-1β expression in both control and TGFβRIIfl/flLysMCre 
wounds. Expression in wounded skin of control and TGFβRIIfl/flLysMCre mice and unwounded skin 
of TGFβRIIfl/flLysMCre mice was normalized over control unwounded skin. Horizontal lines 
represent the mean. Statistical significance was determined using student’s t-test. NS: normal skin, 
W: wound tissue. 
3.3.7 Loss of TGFβRII in macrophages does not impact pro-fibrotic, pro-
inflammatory and pro-angiogenic cytokine regulation in isolated 
wound macrophages 
The wound tissue consists of many cell types and therefore the expression and regulation 
of fibrotic and pro-inflammatory factors can be a mixed response of all the cell types. To 
address the specific contribution of control and TGFβRIIfl/flLysMCre macrophages in the 
generation of fibrotic and inflammatory factors at the wound tissue, macrophages were 
isolated from control and TGFβRIIfl/flLysMCre wounds and used to screen various factors. 
Particularly, the factors which were up-regulated in wound tissues were analyzed in the 
isolated macrophages. To do this, total cells from control and  TGFβRIIfl/flLysMCre wounds 
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at day 4, day 7 post injury were isolated by cell isolation protocol and FACS sorted for 
F4/80 positive macrophages.  
Analysis of TGF-β1 and CTGF on the RNA isolated from wound macrophages at day 4 
and day 7 post injury showed a similar expression pattern of both the genes in control and 
TGFβRIIfl/flLysMCre wound macrophages and correlated with their expression regulation 
pattern in wound tissue at this time point (Fig. 3-14A & see Fig. 3-9, 3-10). This data 
suggests that similar expression of TGF-β1 in control and TGFβRIIfl/flLysMCre wound 
macrophages might be due to compensatory factors that are involved in TGF-
β1 regulation in macrophages.  Previously, we showed that the regulation of CTGF  was 
reduced in the wound tissue from TGFβRIIfl/flLysMCre mice at day 4 post injury (See Fig. 
3-9), however, CTGF regulation in wound macrophages from control and 
TGFβRIIfl/flLysMCre mice showed no difference (Fig. 3-14A) and indicates the involvement 
of other cell types, contributing to the reduced CTGF expression in TGFβRIIfl/flLysMCre 
wounds, probably, myofibroblasts. 
To analyze the influence of TGF-β1 signaling on the regulation of inflammatory cytokines 
and the expression of angiogenic cytokines in wound macrophages, expression of TNF-α, 
IL-1β and VEGF-A was analyzed by real time PCR. TNF-α and IL-1β  are the crucial 
cytokines for the inflammatory phase of wound healing. As expected, both the cytokines 
were highly up-regulated in wound macrophages at day 4 post injury and the expression 
of IL-6 was similar between control and TGFβRIIfl/flLysMCre wound macrophages. By 
contrast, the TNF-α expression in TGFβRIIfl/flLysMCre wound macrophages revealed to 
be reduced compared to control macrophages, although this difference was not significant 
(Fig. 3-14B). In contrast to IL-6 and TNF-α, expression of IL-1β was reduced in 
TGFβRIIfl/flLysMCre wound macrophages compared to the control macrophages (Fig. 3-
14C). This result indicates differential regulation of some pro-inflammatory functions of 
macrophages at the wound site due to the loss of TGFβRII. This effect was macrophage 
specific, as this was not seen in the wound tissue.  
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Fig. 3-14: Similar up-regulation of pro-fibrotic and pro-inflammatory cytokines and less up-
regulation of IL-1β  expression in TGFβRIIfl/flLysMCre wound macrophages. A,B,C) Real time 
PCR analysis of RNA from macrophages isolated from total wound tissue at day 4 and day 7 post 
injury shows similar level of up-regulation of TGF-β1 and CTGF expression (A), TNF-α and IL-6 (B) 
and reduced up-regulation of IL-1β in TGFβRIIfl/flLysMCre wound macrophages compare to control 
wound macrophages (B). Expression in wound macrophages from control and TGFβRIIfl/flLysMCre 
mice, and blood monocytes from TGFβRIIfl/flLysMCre mice was normalized over control blood 
monocytes. Horizontal lines represent the mean. Statistical significance was determined using 
student’s t-test. Mo: blood monocytes, WMΦ: wound macrophages. 
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3.4 Impact of loss of TGFβRII signaling in macrophages on 
bleomycin induced fibrosis 
To elucidate the impact of TGFβRII in the regulation of skin fibrosis in response to 
inflammatory tissue damage, we used a model of bleomycin-induced skin fibrosis. To 
induce fibrosis, 100 µg/ml of bleomycin was injected intra-dermal in control and 
TGFβRIIfl/flLysMCre mice. Mice were sacrificed after two weeks and four weeks of 
treatment for tissue analysis (Fig. 3-15). 
                           
Fig. 3-15: Schematic representation of bleomycin injection to induce cutaneous fibrosis. 
Mice were injected with 1 mg/ml of bleomycin everyday for 2 weeks (A) or 4 weeks (B) and 
sacrificed for tissue analysis, real time PCR as well as cell isolation. 
3.4.1 Abrogation of TGFβRII in macrophages results in reduced bleomycin 
induced fibrosis  
Macroscopically as well as histopathological analysis of the fibrotic skin revealed reduced 
fibrosis and reduction of dermal thickness in TGFβRIIfl/flLysMCre fibrotic skin compared to 
control fibrotic skin after two weeks and four weeks of bleomycin injection (Fig. 3-16A). To 
further confirm the reduced dermal thickness of TGFβRIIfl/flLysMCre fibrotic skin, thickness 
of the dermis was measured. This analysis also showed significant reduction in the dermal 
thickness of TGFβRIIfl/flLysMCre fibrotic skin compared to the control fibrotic skin after two 
and four weeks of bleomycin injection (Fig. 3-16A), supporting the histological 
observations. Interestingly, the phenotype observed in TGFβRIIfl/flLysMCre mice was 
similar to the phenotype observed in bleomycin induced skin fibrosis in complete Smad3 
knock out (Lakos, Takagawa et al. 2004). Since Smad3 is the downstream signaling 
target of TGF-β1, the phenotype observed in Smad3 knock out might be partially due to 
loss of Smad3 in macrophages. Taken together, this result suggests an important role of 
TGF-β1 signaling in macrophages during fibrosis. 
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Fig. 3-16: Attenuated bleomycin induced cutaneous fibrosis in TGFβRIIfl/flLysMCre mice. A) 
Macroscopic picture and H&E staining of fibrotic skin after 2 weeks and 4 weeks of bleomycin 
injection showed reduced fibrosis in TGFβRIIfl/flLysMCre fibrotic skin compared to control fibrotic 
skin. C, D) Microscopic measurment of the dermal thickness in the fibrotic skin after 2 weeks (C) 
and 4 weeks (D) of bleomycin injection showed significant reduction of dermal thickness in 
TGFβRIIfl/flLysMCre fibrotic skin compared to control fibrotic skin. Horizontal lines represent the 
mean. Statistical significance was determined using student’s t-test. NS: normal skin, FS: fibrotic 
skin. 
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3.4.2 Abrogation of TGFβRII in macrophages results in impaired collagen 
deposition in bleomycin induced fibrosis 
We next investigated, whether the reduced dermal thickness in bleomycin induced fibrotic 
skin of TGFβRIIfl/flLysMCre was due to reduced collagen deposition in the fibrotic area. To 
address this question, sections of fibrotic skin were stained with Sirius Red and analyzed 
under light microscope. The analysis revealed reduced collagen content in 
TGFβRIIfl/flLysMCre fibrotic skin compared to control fibrotic skin. Dermal thickness in the 
TGFβRIIfl/flLysMCre fibrotic skin was hence, accompanied by reduced collagen production 
(Fig. 3-17A, B &C).  Furthermore, in real time analysis of collagen-1α1 and collagen-3α1 
in fibrotic dermis, separated from fibrotic skin tended to have less expression of collagen 
in TGFβRIIfl/flLysMCre mice. However, due to variation in samples, this needs further 
analysis (Fig. 3-17D).  
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Fig. 3-17: Reduced collagen deposition in TGFβRIIfl/flLysMCre fibrotic skin. A, B, C) Sirius red 
staining of normal skin (A) and of fibrotic skin (B, C) after 4 weeks of bleomycin injection and 
visualization with polarized light revealed less collagen fibrils in the TGFβRIIfl/flLysMCre fibrotic skin 
compared to control fibrotic skin (B). C) Higher magnification shows a clear distinction in collagen 
bundle structure between control and TGFβRIIfl/flLysMCre fibrotic skin. D) Real time PCR analysis 
of fibrotic dermis separated from fibrotic skin after 4 weeks of bleomycin injection tended to have 
less col-1a1 and col-3a1 expression in  TGFβRIIfl/flLysMCre mice compared to control mice. 
Expression in fibrotic dermis from control and TGFβRIIfl/flLysMCre mice and PBS dermis from 
TGFβRIIfl/flLysMCre mice was normalized over control PBS dermis. Horizontal lines represent the 
mean. Statistical significance was determined using student’s t-test. Bleo: bleomycin, Der: dermis, 
wks: weeks. 
Myofibroblasts are the primary cell type, required for collagen production and ECM 
deposition in fibrotic skin. Therefore, we speculated that either a disturbed auto-induction 
of TGF-β1 synthesis in TGFβRII receptor deficient macrophages or a disturbed 
communication between macrophages and fibroblasts, might contribute to the reduced 
fibrosis observed in TGFβRIIfl/flLysMCre mice. 
3.4.3 TGFβRII deficiency does not affect the number of myofibroblast and 
endothelial cells in bleomycin induced fibrosis  
In order to assess whether reduced collagen deposition correlates with the reduced 
numbers of myofibroblasts in the fibrotic area, the fibrotic tissue was stained for α-SMA. 
The quantification of α-SMA positive areas revealed no significant difference between 
fibrotic area in control and TGFβRIIfl/flLysMCre mice (Fig. 3-18A). Additionally, no 
significant difference in CD31 positive endothelial cellnumbers was observed (Fig. 3-18B).  
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Fig. 3-18: TGFβRII deficiency in macrophages does not impact myofibroblasts 
differentiation and angiogenesis in bleomycin induced fibrosis. A, B) Quantification in fibrotic 
area after 4 weeks of bleomycin injection shows similar increase of α-SMA area (A) and  CD31 
positive area (B) between control and TGFβRIIfl/flLysMCre fibrotic skin. Horizontal lines represent 
the mean. Statistical significance was determined using student’s t-test. Bleo: bleomycin. 
3.4.4 Possible mechanisms involved in the reduced bleomycin induced 
fibrosis of TGFβRIIfl/flLysMCre mice 
In order to find the mechanism behind reduced fibrosis in TGFβRIIfl/flLysMCre mice, we set 
out to investigate different parameters that could potentially contribute to the reduced 
fibrosis. Inflammation is the prerequisite for fibrosis. Inflammatory mediators, secreted by 
immune cells, and cell-cell interactions at the local site are of prime importance to 
generate and sustain fibrotic conditions. Therefore, we analyzed the presence of 
inflammatory immune cells and their contribution to the local cytokine milieu in bleomycin 
induced fibrosis of control and TGFβRIIfl/flLysMCre mice. 
3.4.4.1 Reduced infiltration of myeloid cells in bleomycin induced fibrotic skin of 
TGFβRIIfl/flLysMCre mice 
To find out the contribution of inflammatory immune cells, sections from fibrotic skin of 
control and TGFβRIIfl/flLysMCre mice were stained for Gr-1 positive neutrophils and 
giemsa positive mast cells. Interestingly, a significant reduction in number of Gr-1+ 
neutrophils was observed in the fibrotic area of TGFβRIIfl/flLysMCre mice after 4 weeks of 
bleomycin injection (Fig. 3-19A), however no differences were observed in the number of 
giemsa positive mast cells (Fig. 3-19B). 
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Fig. 3-19: Reduced neutrophils and unaltered mast cells in fibrotic skin after four weeks of 
bleomycin injection. A, B) Immunohistochemistry and quantification in fibrotic area after four 
weeks of bleomycin injection shows significantly reduced number of Gr-1+ neutrophils in 
TGFβRIIfl/flLysMCre mice compared to control mice (A) and similar number of mast cells in control 
and TGFβRIIfl/flLysMCre mice (B). Horizontal lines represent the mean. Statistical significance was 
determined using student’s t-test. Bleo: bleomycin, HPF: high power field. 
To further investigate the altered recruitment of immune cells, cells were isolated from 
bleomycin induced fibrotic area of control and TGFβRIIfl/flLysMCre mice and analyzed by 
FACS using myeloid cell specific surface markers. Interestingly, after 2 weeks of 
bleomycin injection the absolute number of total cells, which were normalized to the total 
tissue weight, was significantly reduced in TGFβRIIfl/flLysMCre mice compared to control 
mice (Fig 3-20A). After 4 weeks, the total number of cells tended to be lower in 
TGFβRIIfl/flLysMCre mice as well, however this needs further investigation (Fig. 3-20A).  
To address whether the reduced numbers of cells were CD11b+ myeloid cells and 
CD11b+/F4/80+ macrophages, the isolated cells were stained for CD11b or double stained 
for CD11b/F/480 and analyzed by FACS. Interestingly, both, the number of total myeloid 
cells as well as macrophages were reduced in the bleomycin treated fibrotic skin of 
TGFβRIIfl/flLysMCre mice after 2 weeks compared to control mice (Fig. 3-20B and C).  
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Fig. 3-20: Reduced number of total myeloid cells and macrophages in fibrotic skin of 
TGFβRIIfl/flLysMCre mice. A, B, C) FACS analysis of cells isolated from fibrotic skin indicated 
reduced number of total cells (A), CD11b+ myeloid cells (B) and CD11b+/F4/80+ macrophages (C) 
in TGFβRIIfl/flLysMCre mice compared to control mice after two weeks of bleomycin injection. 
Horizontal lines represent the mean. Statistical significance was determined using students t-test. 
Bleo: bleomycin. 
3.4.4.2 Altered dermal inflammatory cytokine profile in bleomycin induced fibrotic 
skin of TGFβRIIfl/flLysMCre mice  
Since, TGFβRIIfl/flLysMCre mice showed reduced number of infiltrating immune cells in 
fibrotic skin, we wondered if the local milieu of inflammatory cytokines was also altered. 
To address the contribution of individual skin compartment in the production of local 
cytokine milieu, epidermis and dermis were separated from bleomycin induced fibrotic 
skin by ammonium thiocyanate, followed by RNA isolation and real time PCR of 
inflammatory cytokines.  
Since, the contribution of dermal cells are considered to be of prime importance for the 
generation of fibrotic response, expression of several pro-inflammatory factors such as IL-
1β, TNF-α, osteopontin-1 (OPN-1), IL-6 and MCP-1 was analyzed on dermal RNA from 
fibrotic skin after 2 week of bleomycin injection. Expression of these factors was 
significantly up-regulated in bleomycin injected fibrotic dermis compared to PBS injected 
dermis. However, compared to control fibrotic dermis, in TGFβRIIfl/flLysMCre fibrotic 
dermis, the expression of IL-β, TNF-α and OPN-1 was reduced (Fig. 3-21A), whereas 
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expression of IL-6 and MCP-1 did not differ significantly (Fig. 3-21A). This analysis points 
to a reduced inflammatory response generated during fibrosis in TGFβRIIfl/flLysMCre mice 
compared to control mice and correlates with the reduced infiltration of immune cells.   
Reduced up-regulation of pro-inflammatory factors and reduced infiltration of immune cells 
in TGFβRIIfl/flLysMCre mice compared to control mice after 2 weeks of bleomycin injection, 
posed the question that whether this was a transient differential regulation that drives the 
reduced fibrotic phenotype of TGFβRIIfl/flLysMCre mice or a continuous less regulation of 
these factors are associated with the phenotype. To address this question, dermis was 
separated from fibrotic skin after 4 weeks of bleomycin injection and analyzed for the 
expression of pro-inflammatory cytokines by real time PCR. Fibrotic dermis after 4 weeks 
of bleomycin injection showed a significant differential up-regulation of TNF-α and MCP-1 
in TGFβRIIfl/flLysMCre mice compared to control mice (Fig. 3-21B), whereas, IL-1β and IL-
6 up-regulation was comparable between control and TGFβRIIfl/flLysMCre fibrotic dermis 
(Fig. 3-21B). 
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Fig. 3-21: Differential expression of pro-inflammatory cytokines in the dermis of 
TGFβRIIfl/flLysMCre mice during fibrosis. A, B) Real time PCR analysis of dermis, separated 
from bleomycin injected fibrotic skin after 2 weeks (A) and 4 weeks (B) showed significantly less 
up-regulation of TNF-α, IL-1β and OPN-1 and comparable expression of MCP-1 and IL-6 in 
TGFβRIIfl/flLysMCre mice after 2 weeks compared to control mice (A). Enhanced  up-regulation of 
TNF-α and MCP-1 in TGFβRIIfl/flLysMCre mice compared to control mice and similar up-regulation 
of IL-1β and IL-6 in both control and TGFβRIIfl/flLysMCre mice after 4 weeks of bleomycin injection 
(B). Expression in fibrotic dermis from control and TGFβRIIfl/flLysMCre mice and PBS dermis from 
TGFβRIIfl/flLysMCre mice was normalized over control PBS dermis. Horizontal lines represent the 
mean. Statistical significance was determined using student’s t-test. Bleo: bleomycin, Der: dermis, 
wks: weeks. 
To answer the question whether differential expression of pro-inflammatory cytokines is 
tissue specific, the expression of TNF- α, IL-1β, IL-6 and MCP-1 was also analyzed in the 
separated epidermis in the same samples used previously for dermal gene expression 
analysis. In contrast to the dermal compartment, the expression of TNF- α, IL-1β, IL-6 and 
OPN-1 in fibrotic epidermis of both control and TGFβRIIfl/flLysMCre mice was up-regulated 
to similar level, thus no differential regulation of these genes was observed between 
control and TGFβRIIfl/flLysMCre mice (Fig. 3-22).	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Fig. 3-22: The expression of pro-inflammatory cytokines in fibrotic epidermis of control and 
TGFβRIIfl/flLysMCre mice is not altered. A, B) Real time PCR analysis of fibrotic epidermis 
separated from bleomycin injected fibrotic skin after 2 weeks showed comparable up-regulation of 
expression of TNF-α, IL-1β and OPN-1 and unaltered expression of MCP-1 in both control and 
TGFβRIIfl/flLysMCre mice. Expression in fibrotic epidermis from control and TGFβRIIfl/flLysMCre 
mice and PBS epidermis from TGFβRIIfl/flLysMCre mice was normalized over control PBS 
epidermis. Horizontal lines represent the mean. Statistical significance was determined using 
student’s t-test. Bleo: bleomycin, Epi: epidermis, wks: weeks.	  
3.4.4.3 Similar expression of pro-fibrotic factors in control and TGFβRIIfl/flLysMCre 
fibrotic dermis 
Pro-fibrotic growth factors such as TGF-β, CTGF and PDGF-β, directly or indirectly 
promote accumulation of extracellular matrix as well as proliferation and survival of 
myofibroblast, which is a prerequisite for the collagen production (Bonner 2004). To 
further address the underlying mechanism of reduced fibrosis, expression of pro-fibrotic 
growth factors were determined on the separated dermis from 2 weeks and 4 weeks 
bleomycin induced skin. However, the expression of TGF-β1, CTGF and PDGF-β isoform 
was not altered in fibrotic dermis after 2 weeks (3-23A) and 4 weeks (3-23B) of bleomycin 
injection between control and TGFβRIIfl/flLysMCre mice.          
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Fig. 3-23: Similar expression of pro-inflammatory cytokines between fibrotic dermis of 
control and TGFβRIIfl/flLysMCre mice. A, B) Real time PCR analysis of fibrotic dermis separated 
from bleomycin injected fibrotic skin after 2 weeks (A) and 4 weeks (A) showed no difference in 
expression pattern of  TGF-β1, CTGF, PDGF-β or VEGF-A between both control and 
TGFβRIIfl/flLysMCre mice. Expression in fibrotic dermis from control and TGFβRIIfl/flLysMCre mice 
and PBS dermis from TGFβRIIfl/flLysMCre mice was normalized over control PBS dermis. 
Statistical significance was determined using student’s t-test. Bleo: bleomycin, Epi: epidermis, wks: 
weeks. 
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3.4.4.4 TNF-α  expression in fibrotic skin direct correlates with TNF-α  expression in  
TGFβRII  deficient macrophage isolated from fibrotic skin 
To address the question whether reduced local inflammatory cytokine milieu in fibrotic 
dermis of TGFβRIIfl/flLysMCre mice was directly contributed by macrophages present at 
the fibrotic lesion, F4/80 positive cells were FACS sorted after isolation from fibrotic skin 
and the expression of several genes was analyzed by real time PCR. In particular, 
expression of TNF-α, IL-1β and TGF-β1 was analyzed. Interestingly, the macrophages 
isolated from 2 weeks of bleomycin injected mice showed significantly reduced expression 
of TNF-α in TGFβRIIfl/flLysMCre mice compared to control mice (Fig. 3-24A). This 
observation correlates with the previously observed reduced expression of TNF-α in 
fibrotic dermis at 2 weeks (see Fig. 3-21A). Therefore, this analysis showed a direct 
contribution of macrophages in producing TNF-α in fibrotic skin, which required TGFβRII 
expression on macrophages. Unlike expression of TNF-α , expression of IL-1β and TGF-
β1 was un-altered in the isolated macrophages from 2 weeks of bleomycin injected control 
and TGFβRIIfl/flLysMCre mice (Fig. 3-24B), indicating source of these factors other than 
macrophages at the indicate time point. 
 
Fig. 3-24: Reduced expression of TNF-α  in macrophages isolated from bleomycin injected 
TGFβRIIfl/flLysMCre mice after 2 weeks. A, B,) Real time PCR analysis of TNF-α, IL-1β and TGF-
 β1 in macrophages isolated from bleomycin induced fibrotic skin after 2 weeks showed less 
regulation of TNF-α expression in TGFβRIIfl/flLysMCre mice compared to  control mice (A) and un-
altered expression of IL-1β and TGF- β1 in both the mice. Expression in macrophages from fibrotic 
tissue of control and TGFβRIIfl/flLysMCre mice and from PBS injected tissue of TGFβRIIfl/flLysMCre 
mice was normalized over macrophages from PBS injected tissue of control mice. Horizontal lines 
represent the mean. Statistical significance was determined using student’s t-test. Bleo: bleomycin, 
Epi: epidermis, MΦ: macrophages, wks: weeks.	  
3.4.4.5 Possible mechanisms of reduced fibrosis and less extracellular matrix 
deposition in TGFβRIIfl/flLysMCre mice 
Reduced fibrosis in TGFβRIIfl/flLysMCre mice was associated with the reduced collagen 
deposition, points to a direct mechanism that possibly involves imbalanced turnover of 
collagen deposition and degradation. The turnover of collagen/extracellular matrix is 
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mainly controlled by the balanced production of matrix metalloproteinases and of tissue 
inhibitors of metalloproteinases (TIMPs). TIMPs are known to inhibit matrix 
metalloproteinases (MMPs), which are mainly associated with degradation of extracellular 
matrix (Krane 1985). Interestingly, TIMP-1 production from macrophages has recently 
been speculated to be important for skin fibrosis (Gessner, Hulgens et. al. 2011). 
Moreover, in fibroblasts, TGF-β1 can up-regulate the expression of TIMP-1 (Mattila, Airola 
et al. 1998). To address that whether reduced collagen accumulation in fibrotic area was 
due to imbalanced turnover of collagens and expression of tissue inhibitors of 
metalloproteinases (TIMPs) at the site, expression of TIMP-1 and TIMP-2 was analyzed in 
fibrotic epidermis as well as dermis from 2 weeks bleomycin injected mice. Although, 
expression of TIMP-1 was elevated in dermis (Fig. 3-25A) as well as epidermis (Fig. 3-
25B), the expression level was comparable between control and TGFβRIIfl/flLysMCre mice. 
Analysis of the MMP expression would be the further step to look into the mechanism of 
collagen turn over in fibrotic skin. Although, we have not analyzed the expression of 
MMPs in the fibrotic skin, MMP activity was analyzed by in situ zymography. To do this, 
frozen fibrotic skin section of control and TGFβRIIfl/flLysMCre mice after 4 weeks of fibrosis 
was incubated with gel containing gelatin substrate and the activity was visualized by 
coomassie blue staining. As preliminary results the activity of MMPs was observed in 
control and fibrotic skin (Fig. 3-25C), however whether MMPs are differentially activated in 
TGFβRIIfl/flLysMCre mice need further experiments and analysis.  
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Fig. 3-25: Expression of TIMPs in epidermis and dermis of fibrotic skin after 2 weeks of 
bleomycin injection. A, B) Real time PCR analysis of fibrotic epidermis (B) and dermis (A) after 2 
weeks of bleomycin injection showed comparable up-regulation of TIMP-1 in fibrotic dermis (A) and 
epidermis (B) of control and TGFβRIIfl/flLysMCre mice, whereas TIMP-2 expression was 
downregulated in both dermis (A) and epidermis (B) but not significantly. C) H&E stained sections 
(upper panel), used for in situ zymography of collagenase/MMPs activity on the cryosections, 
placed and incubated on the gel containing gelatinase as a substrate and visualized by commassie 
blue staining (lower pannel). Expression in fibrotic epidermis/dermis from control and 
TGFβRIIfl/flLysMCre mice and PBS epidermis/dermis from TGFβRIIfl/flLysMCre mice was 
normalized over control PBS epidermis/dermis. Statistical significance was determined using 
student’s t-test. Epi: epidermis, Der: dermis, Bleo: bleomycin, wks: weeks.	  
A reduced fibrinolysis and fibrin persistence have been associated with an enhanced 
accumulation of collagen and the development of skin fibrosis. Plasminogen Activator 
Inhibitor (PAI) is the inhibitor of fibrinolysis thereby promote fibrosis  (Dellas and Loskutoff 
2005). A strong correlation between expression of PAI and fibrosis has been noted in 
bleomycin induced pulmonary fibrosis. Mice lacking PAI gene, show a reduced bleomycin-
induced pulmonary fibrosis, whereas, transgenic mice over expressing PAI show a higher 
collagen deposition in bleomycin-induced pulmonary fibrosis (Eitzman, McCoy et al. 1996; 
Senoo, Hattori et al. 2010). Based on the previous findings, we expected lower expression 
level of PAI in blemobycin induced fibrotic skin of TGFβRIIfl/flLysMCre mice. However, 
although, PAI expression was up-regulated in both control and TGFβRIIfl/flLysMCre fibrotic 
epidermis, it was not differentially modulated between control and TGFβRIIfl/flLysMCre 
fibrotic epidermis (Fig. 3-26A). Moreover, in fibrotic dermis expression of PAI was 
unaltered in both bleomycin injected control and TGFβRIIfl/flLysMCre mice compared to 
PBS injected mice (Fig. 3-26B). Further analysis of PAI-1 expression after 4 weeks of 
bleomycin injection would provide a better insight into the involvement of PAI in skin 
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fibrosis. So far, this result shows an association of epidermal PAI expression with skin 
fibrosis. 
 
Fig. 3-26: Similar expression of plasminogen activator inhibitor (PAI-1). A, B) Real time PCR 
analysis of fibrotic epidermis and dermis after 2 weeks of bleomycin injection showed comparable 
up-regulation of PAI-1 expression in epidermis both control and TGFβRIIfl/flLysMCre mice (A) and 
similar expression of PAI in the fibrotic dermis of control and TGFβRIIfl/flLysMCre mice. Expression 
in fibrotic epidermis/dermis from control and TGFβRIIfl/flLysMCre mice and PBS epidermis/dermis 
from TGFβRIIfl/flLysMCre mice was normalized over control PBS epidermis/dermis. Statistical 
significance was determined using student’s t-test. Bleo: bleomycin, Epi: epidermis, Der: dermis, 
wks: weeks. 
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4  Discussion 
The role of TGF-β and macrophages is well described during different phases of tissue 
repair process and fibrosis (Leask and Abraham 2004; Lucas, Waisman et al. 2010). 
However, a cell type specific TGF-β1 mediated function during tissue repair has been 
poorly studied. Using inducible lineage specific deletion of TGFβRII gene in dermal 
fibroblasts, fibroblast specific role of TGFβRII signaling has been addressed recently 
(Denton, Khan et al. 2009). However, the role of TGF-β1 mediated signaling in 
macrophages during repair process and fibrosis has not been studied so far. 
In this project, we have aimed to delineate the function of macrophage specific TGFβRII 
signaling during mechanical tissue injury and bleomycin induced cutaneous fibrosis. In 
particular, we addressed the impact of macrophage specific deficiency of TGFβRII 
signaling on different phases of tissue repair and fibrosis, such as immune cell infiltration, 
angiogenesis, collagen remodeling and fibroblast differentiation. 
Our hypothesis was that TGFβRII signaling in macrophages plays important role in 
physiological healing process and fibrosis. To address the hypothesis, myeloid cell 
specific TGFβRII deficient (TGFβRIIfl/flLysMCre) mice were generated. 
Efficient deletion of TGFβRII and the loss of downstream Smad2 signaling in myeloid cells 
of TGFβRIIfl/flLysMCre mice provided opportunities to explore the functional relevance of 
TGF-β1 mediated functions of myeloid cells in tissue repair and fibrosis. 
4.1 Macrophage specific deficiency of TGFβRII results in 
context-dependent effect on cell migration under in vitro and 
in vivo condition  
TGF-β1 is a potent chemoattractant factor for immune cells (Wahl, Hunt et al. 1987; 
Wiseman, Polverini et al. 1988; Li, Wan et al. 2006) and it also acts as anti-inflammatory 
factor to resolve the inflammation (Ashcroft 1999). To address the role of TGFβRII 
mediated signaling in cell migration under in vivo inflammatory conditions, control and 
TGFβRIIfl/flLysMCre mice were injected with thioglycollate to induce peritonitis. In the 
peritoneal lavage after thioglycollate injection, the total fractions of leukocytes were 
significantly increased in TGFβRIIfl/flLysMCre mice compared to control mice. This result 
indicates that the loss of TGFβRII  in macrophages probably potentiate the inflammation in 
thioglycollate-induced peritonitis model due to the loss of anti-inflammatory effect, leading 
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to the more recruitment of inflammatory immune cells. We could, however, not observed 
any significant difference in the migration of CD11b/F4/80 positive macrophages, 
CD11b/CD115 positive monocytes as well as CD11b/Gr-1 positive neutrophils, indicating 
that may be the leukocytes other than myeloid cells, are recruited more to the 
inflammation site.  
Serum contains latent/ active TGFβ as well as several other growth factors (Childs, Proper 
et al. 1982; Masui, Wakefield et al. 1986) and therefore it was examined that whether the 
deficiency of TGFβRII impaires random migration of macrophages under low and high 
serum condition. TGFβRII deficiency in macrophage resulted in reduced migration of cells 
under low serum condition but not under high serum condition. This suggests that 
TGFβRII indeed impact on the random migration of macrophages under low concentration 
of TGFβ and other growth factors, whereas in high serum, which contains higher 
concentration of several growth factors, the migration was not affected, probably due to 
the compensatory effect of other factors on TGF-β mediated migration. 
4.2 Effect of TGFβRII mediated signaling in macrophage on 
tissue repair 
4.2.1 TGFβRII mediated signaling in macrophage is involved in wound 
contraction  
Mechanical tissue injury was induced in control and TGFβRIIfl/flLysMCre mice to 
understand the role of TGFβRII signaling in macrophage in tissue repair and several 
parameters were analyzed. The loss of TGFβRII signaling in macrophages did not impact 
the overall re-epithelialization process, formation of granulation tissue and neo-
angiogenesis, however significant attenuation of wound contraction was observed in 
TGFβRIIfl/fl LysMCre mice. This result indicates that macrophage specific TGFβRII 
signaling might play a role during repair process. Previously, we have shown in the 
publication by Lucas et.al, that during tissue injury, TGFβRIIfl/flLysMCre mice show a 
hemorrhagic phenotype with increase fibrinolysis in the wound tissue at day 7 post injury, 
suggesting another important aspect of TGF-β1 mediated signaling in macrophages 
during repair process (Lucas, Waisman et al. 2010). 
The process of wound contraction is primarily governed by differentiated fibroblasts i.e, 
myofibroblast, which acquires a contractile phenotype during repair process and helps in 
the contraction of wounds during the healing process. Our result primarily indicates an 
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additive role of TGFβRII signaling in macrophage during this process, however this could 
either be mediated by macrophage or by fibroblasts to which TGFβRII mediated signaling 
in macrophage is an important pre-requisite. To address whether the reduced contraction 
in TGFβRIIfl/flLysMCre wound is associated with altered myofibroblast differentiation and 
function, expression of smooth muscle actin and production of CTGF was analyzed in the 
wound tissue. This result showed an impaired myofibroblast differentiation associated with 
reduced CTGF expression in TGFβRIIfl/flLysMCre wounds. Collagen production from 
activated fibroblasts is the hallmark of myofibroblast function (Hinz 2007) and therefore 
the accumulation of collagen was analyzed in the wound tissue, which showed reduced 
deposition of collagen in TGFβRIIfl/flLysMCre wounds compared to control wounds.  
Interestingly, mice deficient in TGFβRII in dermal fibroblast show phenotype of delayed 
wound healing, delayed wound contraction, reduced collagen deposition and impaired 
myofibroblast differentiation (Denton, Khan et al. 2009), which resembles to the 
phenotype observed in TGFβRIIfl/flLysMCre mice. Therefore, our data add onto the 
previously known role of TGFβ1 in mediating fibroblast differentiation and collagen 
production. However, how can we explain, that the lack of TGFβRII signaling in fibroblast 
or macrophage, leads to the similar phenotype? At this stage, our data suggests that 
impaired fibroblast differentiation could be responsible for the phenotype. We therefore 
hypothesized that the modulation of TGFβRII signaling in macrophage results in impaired 
cross talk between macrophage and fibroblast, which is required for myofibroblast 
differentiation and function. Although, a cross talk between fibroblasts and macrophages 
mediated by paracrine factors in pathological wound repair process has not been studied, 
it has been reported under in vitro condition in different context. Previously it has been 
shown that co-culture of macrophage and fibroblast in hydrogel affects the fibroblast 
proliferation and migration (Zeng and Chen 2010). Moreover, paracrine soluble factors like 
IL-1β , TNF-α and IL-6 from macrophages were found to be important for fibroblast 
mediated cartilage degradation in a mouse model of rheumatoid arthritis (Scott, Weisbrot 
et al. 1997). . Macrophages isolated from control and TGFβRIIfl/flLysMCre mice and its co-
culture with fibroblast under in vitro condition would be a crucial step to look further, if the 
loss of TGFβRII signaling on macrophages affects the fibroblast differentiation by 
secretion of paracrine factors.  
In order to find the paracrine mediators, downstream to macrophage specific TGFβRII 
signaling in TGFβRIIfl/flLysMCre wounds, which might be essential for myofibroblast 
differentiation, expression of several cytokines and growth factors were analyzed in 
wound tissue from control and TGFβRIIfl/fl LysMCre mice at day 4, day 7 and day 14 post 
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injury. At this stage, expression of none of the potential growth factors such as TGF-β1, 
IL-1β or IL-6 was impaired in the TGFβRIIfl/fl LysMCre wound tissue.  
In the wound tissue, several cell types can contribute to the local cytokine milieu and 
therefore the expression of inflammatory factors was analyzed on macrophages isolated 
from wound tissue of control and TGFβRIIfl/fl LysMCre mice. However, expression of all the 
analyzed cytokine was similar between control and TGFβRIIfl/fl LysMCre mice except IL-
1β . Interestingly, it has been shown in previous studies that in macrophages, TGF-β1 
controls regulation of IL-1β (Allen, Manthey et al. 1990; McCartney-Francis, Mizel et al. 
1990). It has also been shown that in vitro, under serum free conditions, IL-1β controls 
collagen production by lung fibroblasts (Elias, Freundlich et al. 1990), and induces 
collagen synthesis by different cell types such as hepatic stellate cells (Zhang and Yao 
2012). Therefore, we proposed that the loss of TGFβRII signaling in macrophages results 
in impaired autocrine interaction of TGF-β1 on macrophages leading to the reduced IL-1β 
expression. However, whether the reduced IL-1β expression was involved in the 
macrophage-fibroblast cross talks and contributed to the impaired wound contraction and 
reduced collagen accumulation in TGFβRIIfl/fl LysMCre mice, requires further investigation.  
Although, TGF-β1 is known to auto-induce its own production (Wahl, McCartney-Francis 
et al. 1990) and this could be one of the primary factors mediating mechanisms of 
impaired cross talk of macrophage and fibroblast, both, in wound tissue and isolated 
macrophages, expression of TGF-β1 was similar between TGFβRIIfl/fl LysMCre mice 
compared to control mice. This result could either indicate compensatory expression of 
TGF-β1 from different cell types such as epithelial cells, neutrophils, endothelial cells, 
fibroblasts (Li, Wan et al. 2006), which are known to produce TGF-β1. Since, mRNA 
expression of TGF-β1 does not necessarily correlates with the protein expression 
(Assoian, Fleurdelys et al. 1987; McCartney-Francis, Mizel et al. 1990), alternatively, 
expression of TGF-β1 may be altered at the protein level and activation state in TGFβRIIfl/fl 
LysMCre wounds, which we did not addressed so far.  
4.2.2 TGFβRII mediated signaling in macrophage does not impact cell 
recruitment in wound tissue  
TGF-β1 is known to mediate monocyte recruitment (Wiseman, Polverini et al. 1988), 
therefore it was investigated that whether the deficiency of TGFβRII in macrophages 
impacts on cell migration in vivo during tissue repair. We found that under in vivo situation, 
loss of TGFβRII in macrophages did not alter the overall recruitment of CD11b/F4/80 
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positive macrophages or CD11b/Gr-1 positive neutrophils. This result can be explained by 
the fact that in vivo chemotaxis of monocytes can be mediated by many other chemokines 
produced at the wound site, such as CCL2and MIP-1α (DiPietro, Polverini et al. 1995; 
DiPietro, Burdick et al. 1998). Hence, the overall kinetics of monocyte recruitment 
remained unaltered between control and TGFβRIIfl/flLysMCre wounds. 
Previous studies showed that TGF-β1 induces angiogenesis under in vivo conditions 
(Roberts, Sporn et al. 1986; Ferrari, Cook et al. 2009). Moreover, TGF-β1 can induce 
VEGF-A in macrophages, which is an essential mediator of angiogenesis (Wiseman, 
Polverini et al. 1988; Jeon, Chae et al. 2007). Due to the loss of TGFβRII mediated 
signaling, it was assumed that VEGF-A production and angiogenesis will be impaired in 
TGFβRIIfl/flLysMCre wounds. However, in contrast to this, expression of VEGF-A and 
CD31 positive cells remained unaltered between control and TGFβRIIfl/flLysMCre wounds. 
This could be possibly explained by the previous known fact that several cell types such 
as endothelial cells and epithelial cells can also produce VEGF-A (Brown, Yeo et al. 1992; 
Frank, Hubner et al. 1995; Lee, Chen et al. 2007) and thereby sufficiently contribute to the 
overall VEGF-A expression during wound healing. 
4.3 Impact of TGFβRII mediated signaling in macrophage on 
fibrosis 
4.3.1 TGFβRII mediated signaling in macrophage generates fibrotic 
response 
It is well studied that increased ECM deposition is a hallmark of fibrosis. Fibroblasts as a 
cell type and TGF-β1 as a soluble mediator are of prime importance in contributing 
collagen production in fibrosis (Eckes, Mauch et al. 1996; Jelaska, Arakawa et al. 1996; 
Kawakami, Ihn et al. 1998). However, macrophage specific role of TGF-β1 signaling in 
generating fibrosis is still unknown. To this direction, our data show an essential role of 
macrophage specific TGFβRII signaling in fibrosis. 
Here we show, that the macrophage specific TGFβRII signaling is essential to generate 
inflammation-induced early and late fibrotic response in mice. In the absence of TGFβRII 
signaling in macrophages, TGFβRIIfl/flLysMCre mice exhibit reduced fibrosis, accompanied 
by the reduced dermal thickness and the reduced collagen deposition. Interestingly, the 
fibrotic response observed in the TGFβRIIfl/flLysMCre mice was similar to the phenotype 
observed in mice lacking Smad3, which is a downstream signaling molecule of TGFβRII 
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(Lakos, Takagawa et al. 2004). In the study by Lakos et.al, mice lacking Smad3 also 
showed a reduced bleomycin induced fibrotic response, however complete lack of Smad3 
in this mouse model limits the study to find the cell type specific role of Smad3. At this 
point, our data suggests that macrophage-specific TGFβRII signaling axis might be an 
important contributor to the fibrosis.  
4.3.2 TGFβRII mediated signaling in macrophages results in reduced 
expression of pro-inflammatory factors 
To find out the possible mechanisms involved in the reduced fibrotic response due to 
macrophage specific loss of TGFβRII signaling, the early and late inflammatory response 
was further investigated in control and TGFβRIIfl/flLysMCre mice. Interestingly, after two 
weeks of bleomycin injection, TGFβRIIfl/flLysMCre mice showed reduced number of 
myeloid cells/macrophages compared to control mice. This data shows that macrophages 
specific TGFβRII signaling is associated with recruitment of these cells in fibrosis. Since 
under normal conditions, the recruitment of myeloid cells in the blood of control and 
TGFβRIIfl/flLysMCre mice were similar as studied by FACS analysis of blood cells for 
myeloid cell markers (data not shown), we proposed that the difference observed in the 
recruitment of cells in TGFβRIIfl/flLysMCre mice was bleomycin induced and mediated by 
TGFβRII signaling in macrophages during fibrosis.  
Since, inflammation is the pre-requisite to induce fibrosis and TGFβRIIfl/flLysMCre mice 
showed reduced number of inflammatory cells, this might be associated with reduced 
inflammatory response generated in TGFβRIIfl/flLysMCre mice leading to reduced fibrosis. 
Therefore, the next question was why does a TGFβRIIfl/flLysMCre mice show less immune 
cell infiltration and what makes the inflammatory response in TGFβRIIfl/flLysMCre mice 
different from control mice? A most likely explanation would be that TGFβRIIfl/flLysMCre 
mice are unable to recruit sufficient macrophages or myeloid cells at the fibrotic site and 
therefore as a consequence, less inflammatory cytokines are produced, which are 
probably required for the paracrine interaction with fibroblast, and collagen deposition. 
To address this hypothesis, expression of several inflammatory mediators was analyzed 
in bleomycin injected fibrotic skin. Interestingly, TGFβRIIfl/flLysMCre mice showed a 
differential down-regulation of inflammatory mediators, such as TNF-α, IL-1β and 
osteopontin-1 (OPN-1) in the early fibrotic phase. This result suggests that these factors 
might be important for the reduced inflammation and reduced collagen production in 
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TGFβRIIfl/flLysMCre fibrotic tissue, either by direct involvement or by mediating paracrine 
interaction between macrophage and fibroblast. Since these are less produced in 
TGFβRIIfl/flLysMCre fibrotic tissue, the fibrotic response is attenuated. 
Seemingly, all of the less regulated cytokines in TGFβRIIfl/flLysMCre mice have previously 
been associated with the generation of fibrotic response and collagen production in vitro 
and in vivo. OPN-1 is a glycoprotein, which has cytokine-like properties. It is a 
chemotactic and activating factor for several cell types such as macrophages and T-cells 
(Weber, Zawaideh et al. 2002; Buback, Renkl et al. 2009). It is also a pro-fibrotic factor 
(Pardo, Gibson et al. 2005). It is secreted by many immune cells such as macrophages, 
and has been shown to be involved in myofibroblast differentiation and repair process 
(Lenga, Koh et al. 2008; Mori, Shaw et al. 2008; Buback, Renkl et al. 2009). Interestingly, 
mice lacking OPN-1 show reduced bleomycin-induced lung fibrosis with reduced 
production of active TGF-β1 (Berman, Serlin et al. 2004). Moreover, knock down of OPN-
1 reduces the immune cell recruitment and type I collagen production in vivo, during repair 
process (Mori, Shaw et al. 2008). Although, in macrophages, relation between OPN-1 and 
TGF-β1 has not been established, in various other cells such as osteoblasts and HeLa 
cells, TGF-β1 has been shown to up-regulate the expression of OPN-1 (Fagenholz, 
Warren et al. 2001; Piva, Gavassini et al. 2012). In a co-culture of macrophage and 
fibroblasts, macrophage secreted factors have been found to regulate OPN-1 expression 
from fibroblast and therefore OPN-1 expression is indeed regulated during fibroblast-
macrophage interaction If TGF-β1 mediates expression of OPN-1 in macrophages as well, 
it can be well explained that due to loss of TGFβRII in macrophages, expression of OPN-1 
has been impaired. Moreover, OPN-1 expression from macrophages has recently been 
speculated to be important for skin fibrosis (Gessner, 2011). TGF-β1 mediated signaling in 
macrophage directs fibroblast to secrete OPN-1 and since in TGFβRIIfl/flLysMCre mice this 
signal is lacking, less OPN-1 was produced from fibroblasts for proper function, which 
leads to the observed phenotype. This possibility is based on the observation made by 
Mori et.al. (Mori, Shaw et al. 2008), who showed that macrophages produce inductive 
signals for OPN-1 regulation from fibroblasts, however the pathway, which provides this 
signal is unknown. Taken together, based on the previous known role of OPN-1, it is likely 
that the reduced expression of OPN-1 may have contributed to the reduced immune cell 
infiltration, reduced collagen deposition and reduced fibrosis in TGFβRIIfl/flLysMCre mice. 
However, in vitro stimulation of macrophages with recombinant TGF-β1 and expression 
analysis of OPN-1 will address the point that whether OPN-1 expression in macrophages 
is regulated by TGF-β1 and further experiment would identify that whether OPN-1 
expression is linked to the observed phenotype in TGFβRIIfl/flLysMCre mice.  
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Similar to OPN-1, TGFβRIIfl/flLysMCre mice showed down-regulation of IL-1β expression 
in fibrotic dermis compared to control mice. IL-1β has been variably reported to either up-
regulate or down-regulate collagen production from fibroblasts. Under in vitro condition, 
recombinant IL-1 has been found to up-regulate collagen synthesis in lung fibroblasts 
(Elias, Freundlich et al. 1990), moreover in rheumatoid synovial cells/fibroblasts, 
mononuclear cells derived IL-1β have been shown to up-regulate collagen mRNA (Krane, 
Dayer et al. 1985). In another study, IL-1 homologue from monocyte culture supernatant 
has been shown to down-regulate collagen production from normal dermal fibroblast and 
scleroderma fibroblasts (Whiteside, Buckingham et al. 1984). However, these studies 
have been done in vitro, and an in vivo situation can be dependent on various other 
factors and could either be two of them, which has not been studied so far. Therefore, the 
reduced expression of IL1β in fibrosis of TGFβRIIfl/flLysMCre mice can either directly or 
indirectly involved in the observed reduced fibrosis and reduced collagen production, 
which needs further investigation 
4.3.3 Loss of TGFβRII mediated signaling in macrophage results in reduced 
expression of TNF-α  
Another pro-inflammatory factor, TNF-α was consistently down regulated in the fibrotic 
dermis (2 weeks) as well as in the isolated macrophages from the fibrotic tissue (2 weeks) 
of TGFβRIIfl/flLysMCre mice as compared to control mice. However, after 4 weeks of 
bleomycin injection, TNF-α regulation was significantly up-regulated more in the fibrotic 
dermis of TGFβRIIfl/flLysMCre mice compared to control mice, indicating a dual role of 
TNF-α, which involves transient down-regulation of TNF-α, followed by up-regulation at 
the later stage of fibrosis in TGFβRIIfl/flLysMCre mice.  
Under in vivo condition, the role of TNF-α has been described as suppressor as well as 
activator of pulmonary fibrosis. It has been shown that after 2 weeks of bleomycin 
injection, TNF-α is up-regulated and if treated with anti-TNF-α IgG antibody, fibrosis and 
collagen production can be restored to the normal level with reduction in macrophages 
and other cells (Piguet, Collart et al. 1989; Zhang, Gharaee-Kermani et al. 1997). In 
contrast to these reports, which showed pro-inflammatory role of TNF-α, anti-inflammatory 
action of TNF-α has also been reported in \ pulmonary fibrosis. Mice lacking TNFR p55, 
which is one of the receptors for TNF-α has been shown to generate strong bleomycin 
induced fibrosis, accompanied by reduced expression of MMP-1, leading to reduced 
collagen degradation (Murota, Hamasaki et al. 2003). In another study, mice lacking TNF-
α showed an intense pulmonary fibrosis due to the persistent inflammation and the 
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reduced apoptosis of inflammatory cells (Kuroki, Noguchi et al. 2003). On the other hand, 
transgenic mice overexpressing TNF-α showed abrogated bleomycin induced fibrosis and 
reduced collagen production (Fujita, Shannon et al. 2003), which also show an anti-
inflammatory and anti-fibrotic role of TNF-α during pulmonary fibrosis. Reduced fibrosis in 
TGFβRIIfl/flLysMCre mice, accompanied by the reduced TNF-α expression at the early 
stage and enhanced TNF-α regulation at the later stage suggest that in the early stage, 
reduced inflammation might be the consequence of reduced pro-inflammatory action of 
TNF-α, leading to reduced fibrosis, reduced immune cell infiltration, accompanied by 
reduction in other pro-inflammatory cytokines such as IL-1β and OPN-1. Whereas, at the 
later stage, over production of TNF-α led to its anti-inflammatory function resulted in 
reduced fibrosis and reduced collagen deposition. Our data also show that this effect of 
TNF-α requires TGFβRII mediated signaling in macrophages. 
In vivo dual role of TNF-α also correlates with in vitro studies, where the role of TNF-α on 
collagen production by fibroblasts has been variably reported. Whereas, in several 
reports, TNF-α has been shown to down-regulate ECM deposition either by inducing 
production of collagenase or by inhibition of collagen synthesis (Scharffetter, Heckmann et 
al. 1989; Mauviel, Lapiere et al. 1994; Greenwel, Tanaka et al. 2000; Verrecchia, Wagner 
et al. 2002), several other reports showed that TNF-α up-regulates expression of type I 
and type III collagen in fibroblasts (Elias, Freundlich et al. 1990; Sarkar, Vellaichamy et al. 
2004). However, in vitro conditions can be very different from in vivo situation, where a 
complex network of cells and soluble factors contribute to a cumulative phenotype of 
fibrosis. Moreover, all the reports, which describe TNF-α and collagen are context 
dependent and involve activation of other pathways such as JNK and NF-κB. 
In conclusion, this study reveals previously unknown function of macrophage specific 
TGFβRII signaling during repair process and fibrosis. The study further supports the 
previous known in vitro role of TGF-β1 mediated signaling such as collagen production, 
induction of pro-inflammatory factors etc under in vivo situation. The novel insight from the 
study, which we obtained are: First, macrophage specific TGFβRII signaling mediates 
fibrosis. Second, macrophage specific TGFβRII signaling is involved in the regulation of 
pro-inflammatory cytokines such as TNF-α, IL-1β and PN-1 and accumulation of immune 
cells. Third, macrophage specific TGFβRII signaling facilitates wound contraction, 
probably through paracrine interaction between macrophages and fibroblasts during repair 
process.  
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4.4 Hypothetical model for fibrosis mediated by TGFβRII 
signaling in macrophages 
 
 
 
 
Fig. 4-1: Model for TGFβRII mediated function in macrophages during fibrosis. During 
fibrosis, early recruitment of myeloid cells in the skin produce inflammatory cytokines such as IL-
1β, TNF-α, IL-6, MCP-1, leading to either autocrine interaction of the secreted factors on the same 
cells such as macrophage or on the other cells such as fibroblast. The interaction between cells 
and soluble mediators then activate ECM deposition, leading to severe fibrosis. However, 
deficiency of TGFβRII on macrophages results in the reduced accumulation of inflammatory cells 
and the reduced production of inflammatory mediators, leading to impaired autocrine or paracrine 
interaction mediated by these factors. The impaired interaction then leads to reduced activation of 
cells for ECM deposition and reduced fibrosis.  
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5 Materials and Methods  
5.1 Materials 
5.1.1 Buffers used  
Ammoniumthiocynate (pH 6.8): 0.1 M NaKHPO4, 5 mM NH4SCN,  
Anticoagulation buffer: 1 mM EDTA in PBS supplemented with Heparin (1:4000, 
Heparin-Natrium-25,000-ratiopharm®, Ratiopharm GmbH, Ulm, Germany) 
ACK lysis buffer: 150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA  
FACS buffer: 1% BSA, 2 mM EDTA in PBS 
PBS: 10 mM Na2HPO4, 1.5 mM KH2PO4; 2.6 mM KCl, 136 mM NaCl, pH 7.4 
TAE buffer (pH 8.0): 40 mM TrisHCl 20 mM NaAc, 1 mM EDTA  
TE buffer (pH 8.0): 10 mM TrisHCl, 1 mM EDTA  
5x loading dye: 40% Glycerol, 0.04% bromphenol blue, 0.2% orange G, 1 mM EDTA  
Tail lysis buffer (pH 8.0): 100 mM Tris-HCl, 5 mM EDTA, 0.2% (w/v) SDS, 0.2 M NaCl, 
500 mg/ml proteinase K  
Endogenous peroxidase blocking solution: 0.03% H2O2 and 0.15 mol/L NaN3 in PBS 
RIPA buffer: 50 mM Tris/HCl (pH 7.4), 1% NP-40, 0.25% Na-deoxycholate, 150 mM 
NaCl, 1 mM EDTA supplemented with mammalian protease inhibitors (Sigma-Aldrich).and 
phosphatase inhibitor (Roche). 
MES buffer (pH 7.3): 2.5 mM MES, 2.5 mM Tris base, 0.005% SDS, 0.005 mM EDTA 
Transfer buffer (pH 7.2): 25 mM Bicine, 25 mM Bis-Tris (base free), 1 mM EDTA 
Tris-buffered saline (TBS) (pH 7.6): 0.5 M Tris base, 1.5 M NaCl  
Membrane blocking solution: 5% dried milk powder in Tris-buffered-saline, 
supplemented with Tween20 (TBS-T) 
Membrane Stripping buffer (pH 2.2): 0.2 M Glycin, 0.1% SDS, 1% Tween 20 
Transfer buffer: 5 M NaOH, 5M NaCl, distilled water 
Denaturation buffer: 0.25 N HCl, 37%HCl, distilled water 
SSC buffer (20x, pH 7): 0.3 M Na-Citrate, 3M NaCl 
Tris-HCl buffer (pH 7.4): 50 mM Tris-HCl, 5 mM CaCl2 
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Coomassie blue: 0.01% Coomassie blue R-250, 50% MeOH, 5% acetic acid 
Destaining solution: 10% MeOH, 10% acetic acid 
5.1.2 Chemicals and reagents 
Name Company 
Bleomycin (Bleomedac)  Medac Gesellschaft, Germany 
DMEM medium Invitrogen, Darmstadt, Germany 
Penicillin/Streptomycin Biochrom, Berlin, Germany 
Fetal Calf Serum (FCS) PAA, Pasching, Austria 
Normal goat serum DakoCytomation Inc., Carpinteria, USA 
Bovine serum albumin Carl Roth GmbH, Germany 
EDTA Biochrom AG, Germany 
AEC substrate DakoCytomation Inc., Carpinteria, USA 
Antibody diluent DakoCytomation Inc., Carpinteria, USA 
β-mercaptoethanol Sigma, USA 
NuPAGE 4-12% Bis-Tris Gel  Invitrogen, USA 
NuPAGE MES SDS running buffer Invitrogen, USA 
Mammalian protease inhibitor cocktail Sigma-Aldrich, USA 
PhosStop phosphatase inhibitor  Roche, F. Hoffmann-La Roche Ltd, Basel, Switzerland 
LDS-sample loading buffer Invitrogen, USA 
Western Lightning Chemiluminsecence 
Reagent 
Perkin Elmer, USA 
Page Ruler pre-stained     Fermentas GmbH, St. Leon-Rot, Germany 
peqGOLD 50 & 1 kb bp ladder Peqlab, Erlangen, Germany 
Agarose  Bio-Budget, Germany 
DNA Salmon sperm Sigma-Aldrich, USA 
10X Tango buffer Fermentas, Germany 
Quick Hyb Hybridization solution Stratagene, Germany 
Ketanest S (25 mg/ml) Park Davis GmbH, Karlsruhe, Germany 
Rompun (2%) Bayer HealthCare AG, Germany 
Isofluoran Abott, Germany 
Ammonium thiocyanate (NH4SCN) Sigma, USA 
Thioglycollate (4%) Sigma-Aldrich, St. Louis, USA 
Tissue Tek O.C.T. Compound  Miles, Elkhart, IN, USA 
Tween 20 Merck, Darmstadt, Germany 
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5.1.3 Commercial Kits  
 
5.1.4 Recombinant proteins and enzymes 
5.1.5 Technical equipments and softwares 
Medimachine BD Biosciences, Germany 
7300 Real Time PCR system Applied Biosystems, Carlsbad, CA, USA 
T3000 Thermocycler Biometra, Göttingen, Germany 
Flow Cytometers (FACSDiva software) FACS CantoTM (BD, Heidelberg, 
Germany) 
Graph Pad Prism and Software GraphPad Software, Inc., San Diego, CA, 
USA 
Light microscope; Leica DM 4000B 
(Diskus 4.50 Software) 
Carl H. Hilgers, Königswinter, Germany 
Nikon eclipse E800 (NIS-Elements AR 
2.30 Software) 
Nikon, Melville, NY, USA 
Olympus 1X81 microscope system Tokyo, Japan 
Image J Bethesda, MD, USA 
Kits Company 
BCA Protein Assay Reagent Kit Pierce Protein Research Products, Thermo 
Scientific 
RNeasy Micro Kit Qiagen, Hilden, Germany 
RNeasy Plus Mini Kit Qiagen, Hilden, Germany 
RNeasy Fibrous Tissue Kit Qiagen, Hilden, Germany 
High Capacity cDNA Reverse 
Transcription Kit 
Applied Biosystems, Carlsbad, CA, USA 
QIAquick Gel Extraction kit Qiagen, Hilden, Germany 
Ladderman probe labeling unit Takara, Japan 
QuickZyme Total Collagen Assay QuickZyme biosciences, Leiden, Netherlands 
Protein Concentration Company 
rTGF-β1 20 ng/ml eBioSciences Inc, San Diego, USA 
Taq DNA Polymerase 100 ng/ml Bio Budget, Krefeld, Germany 
DNase I 30 K unit Qiagen, Hilden, Germany 
Liberase 0.15 U/ml Roche Applied Science, Germany 
Proteinase K  500 mg/ml Sigma-Aldrich, Germany 
NCoI  2 U/10 µg DNA Fermentas, Germany 
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Gel documentation  Peqlab, Germany 
Mixer mill MM 400  Retsch, Germany 
Victor Multilabel reader  Perkin Elmer, USA 
Biophotometer Eppendorf, Germany 
Hybridization roller bottle GL45 Witeg, Germany 
Illustra ProbeQuant G-50 microcolumns GE Healthcare. USA 
Metallblock thermostat (Heating block) Bachhofer GmbH, Reutingen, Germany 
Hybridization oven OV-10 Biometra, Goettingen, Germany 
Scintillation counter LC-6500 Beckmann, USA 
Contamat FHT 111M Medizin-GmbH, Duesseldorf, Germany 
5.1.6 Other materials 
Name Company 
Optical adhesive film Applied Biosystems, UK 
96 well plates Applied Biosystems, Singapore 
40 µm nylon filter BD Biosciences, Germany 
70 µm nylon filter BD Biosciences, Germany 
Centrifuge tubes (15/50 ml) BD FalconTM, Germany 
Polylysine glass slides Menzel GmbH, Germany 
Medicons BD Biosciences, Germany 
Thermo mixer Eppendorf, Hamburg, germany 
PVDF membrane (8 µm pore size) Millipore Corporation, Billerica, USA 
Biopsies Punch (5-8 mm) Stiefel, Offenbach, Germany  
Nitrocellulose membrane GE healthcare, USA 
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5.1.7 Primary antibodies 
Table 5-1 
Antibodies Host/Isotype Clone Dilution Company 
β-Actin Mouse C4 WB: 1/1000 Santa Cruz biotechnology, Germany 
α-SMA-Cy3 Mouse IgG2a 1A4 IF: 1:250 Sigma-Aldrich, St. Louis, MO, USA 
CD11b-PE/APC Rat IgG2b 
 
FC: 1:100 FC: 1/100 BD Pharmingen, Germany 
CD19-APC Rat IgG2a 1D3 FC: 1/100 Miltenyi, Bergisch Gladbach, 
Germany 
CD31 (Pecam-1) Rat IgG2a MEC 13.3 IF: 1/1000 BD Pharmingen, Heidelberg, 
Germany 
CD115-APC Rat IgG2a AFS98 FC: 1/250 eBioscience Inc., San Diego, USA 
CD16/32  Rat IgG2a 93 FC: 1:60 eBioscience Inc., San Diego, USA 
ERK1/2 Rabbit Polyclonal WB: 1/1000 Cell Signaling Technology 
F4/80 Rat IgG2a  BM8 IF: 1/200 Dianova BMA AG, Augst, 
Switzerland 
F4/80-PE/FITC Rat IgG2a BM8 FC: 1:200 AbD Serotec, Düsseldorf, Germany 
Gladbach, Germany 
Gr-1 Rat IgG2b RB6-8C5 IHC: 1/150 BD Pharmingen, Heidelberg, 
Germany 
Gr-1-PE Rat IgG2b RB6-8C5 FC: 1/10 Miltenyi, Bergisch Gladbach, 
Germany 
P-Smad-2 
(Ser465/478) 
Rabbit Polyclonal WB: 1000 Cell Signaling Technology 
Smad-2 Rabbit L16D3 WB: 1000 Cell Signaling Technology 
TGFβRII Rabbit Polyclonal WB: 1/1000 SantaCruz Biotechnology, Germany 
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5.1.8 Secondary antibodies 
Table 5-2: 
Antibodies Dilution Company 
Goat anti rat (H+L)-
Alexa 488 
 
 
1:500 Invitrogen, Paisley, UK 
Swine anti-rabbit-HRP 1:1000 Dako, Glostrup, Denmark 
Rabbit anti-mouse-HRP 1:1000 Dako, Glostrup, Denmark 
Goat anti-rat-IgG+M (H+L)-HRP 1:250 Southern Biotech, USA 
5.1.9 Oligonucleotides  
Table 5-3: Quantitative real time PCR primers for murine genes (5´→ 3´) 
mS18 FP: GATCCCAGACTGGTTCCTGA  
RP: GTCTAGACCGTTGGCCAGAA  
mIL-1β FP: GGACCCCAAAAGATGAAGGGCTGC  
RP: GCTCTTGTTGATGTGCTGCTGCG  
mIL-6 FP: ACACATGTTCTCTGGGAAATC  
RP: AAGTGCATCATCGTTGTTCATACA  
mCTGF FP: CCTCCGTCGCAGGTCCCATCA  
RP: CCATAGCAGGCCGGGTGCAG  
TGF-β1 FP: TGGAGCAACATGTGGAACTC  
RP: GTCAGCAGCCGGTTACCA  
mTIMP-1 FP: GCATTGAGCTTTCTCAAAGACC 
RP: AGGGATAGATAAACAGGGAAACACT 
mTIMP-2 FP: AGGTACCAGATGGGCTGTGA 
RP: GTCCATCCAGAGGCACTCAT 
mCol1-α1 FP: AGCTTTGTGGACCTCCGGCT 
RP: ACACAGCCGTGCCATTGTGG 
mCol3-α FP: GTTTTATGACGGGCCCGGTGC 
RP: GACCAAGGTGGCTGCATCCCA 
mTNF-α FP: GACCCTCACACTCAGATCATCTTCT  
RP: CCTCCACTTGGTGGTTTGCT  
mPAI-1 FP: CTCCTCATCCTGCCTAAGTT 
RP: GCCAGGGTTGCACTAAACAT 
mOPN-1 FP: GCCTCCTCCCTCCCGGTGAAA 
RP: TCCTCGCTCTCTGCATGGTCT 
mPDGF-b FP: AGTCGGCATGAATCGCTGCTG 
RP: TCCGGAGTGTGCTCGGGTCAT 
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miNOS FP: CCACCTTGGTGAAGGGACTGAGCT  
RP: AGGGGCAAGCCATGTCTGAGACT  
mVEGF-A FP: TGTACCTCCACCATGCCAAGT  
RP: TCGCTGGTAGACGTCCATGAA  
 
 
Table 5-4: Genotyping primer sequence and amplicons (5´→ 3´) 
Mouse Primer Sequence  Product size (bp) 
LysMCre FP: 5 ́- CTTGGGCTGCCAGAATTTCTC -3 ́ 
RP: 5 ́- TTACAGTCGGCCAGGCTGAC -3 ́ 
LysMCre: 750 
WT: 350 
TGFβRII FP: 5 ́-GCACAGGTACACATCTCTGCAC-3 ́ 
RP: 5 ́-TGTAATCGTTGCACTCTTCCATGT -3 ́  
WT: 500 
FL: 550 
 
 
 
Table 5-5: Exon 2 specific TGFβRII southern blot probe 
Exon 2  Primer Sequence  Product size (bp) 
TGFβRII FP: 5 ́-CCTCAGTTAACAGTGATGTCATGG -3 ́ 
RP: 5 ́-GAAAGCCAGAGGAGGCCACAG -3 ́  
737 bp 
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5.2 Methods  
5.2.1 Flow cytometry 
5.2.1.1 Single cell suspension 
5.2.1.1.1 Isolation of peritoneal cells 
Mice were sacrificed and peritoneal cavity was flushed with approximately 8 ml of ice-cold 
FACS buffer. The obtained cells were centrifuged at 300 g for 8 minutes at 4°C and the 
pellets were re-suspended in 1 ml FACS buffer. The cells were then counted in Neubauer 
counting chamber and used for cell surface staining and FACS analysis. 
5.2.1.1.2 Isolation of skin cells from wound tissue and bleomycin fibrotic tissue 
The cells were isolated from wound and fibrotic tissue by combination of enzymatic and 
mechanical digestion. Wound tissue at day 4, day 7 and day 14 post injury or bleomycin 
induced fibrotic tissue after 2 weeks and 4 weeks of injection was excised, minced and 
digested in liberase blendzyme (0.15 U/ml) in DMEM (Dulbecco’s modified eagle medium) 
for 90 minutes at 1000 rpm and 37°C on a thermomixer. Subsequently, the mechanical 
digestion was accomplished using BDTM Medimachine for 5 minutes in PBS containing 
10% FCS at room temperature and filtered through 70 µm cell strainer. The cell 
suspension was centrifuged at 300 g for 8 minutes at 4°C and mixed with PBS/2mM 
EDTA followed by additional filtration through 40 µm cell strainer. The suspension was 
centrifuged and the pellets were re-suspended in 1 ml FACS buffer followed by counting 
and staining for FACS analysis. 
5.2.1.1.3 Blood leukocyte isolation  
Mice were sacrificed and blood was taken from the heart in 5 ml of anticoagulation buffer 
and centrifuged at 300 g for 8 minutes at 4°C. Erythrocytes were lysed by adding 5 ml of 
ACK lysis buffer two times for 8 minutes at room temperature. The reaction was stopped 
by addition of 45 ml of ice-cold FACS buffer and subsequently, the filtered through a 70 
µm cell strainer. The cell suspension was centrifuged and the cells were re-suspended in 
1 ml FACS buffer before counting. 
5.2.1.2 FACS staining and analysis 
The final cell suspension in FACS buffer was taken in 2 ml of FACS tube, centrifuged at 
300 g for 8 minute at 4°C and the pellets were re-suspended in 60 µl of FACS buffer. 
Subsequently, the cells were incubated with Fcγ receptor blocking antibody CD16/32 for 
   Materials and methods 
	   	   	  
68	  
10 minute on ice, followed by incubation with cell surface marker antibody at the dilution 
specified in the table 5-1. Minimum 20,000-50,000 cells were counted using BD 
FACSCantoTM machine and analyzed using the FACSDiva software. 
5.2.2 Isolation of genomic DNA  
Mouse tail biopsies or isolated cells from peritoneal cavity were incubated in tail lysis 
buffer on a thermo mixer at 56°C over night followed by centrifugation at 13,000 rpm and 
precipitation by adding an equivalent of isopropanol and centrifugation at 13,000 rpm for 
10 minutes. The obtained DNA pellets were washed with 500 µl of 70% ethanol at 13,000 
rpm, air dried at room temperature for approximately 2 h and re-suspended in 125 µl (in 
case of tail biopsies) or 30 µl (in case of cultured cells) 1x TE buffer.  
5.2.3 Polymerase chain reaction (PCR)  
For genotyping PCR, 10-100 ng template DNA was amplified in a reaction volume of 25 µl 
containing 2 mM MgCl2, 200 nM each primer, 200 µM dNTPs and 0.05 U/µl Taq-
Polymerase in 1x reaction buffer. The optimal annealing temperature of the specific 
primers was estimated with the following formula: TA=59.9+0.41(GC%)-600/L (GC%, GC 
content in percent, L, total number of base pairs). All primers used for genotyping are 
listed in table. 5-4. PCR amplified DNA fragments were analyzed following addition of 5x 
loading dye and gel electrophoresis on 1.5% (w/v) agarose gels (1x TAE, 0.5 mg/ml 
ethidium bromide) at 120 V. The bands were visualized under UV-light (peqlab Gel 
Documentation system) 
5.2.4 RNA extraction, reverse transcription PCR and quantitative real time 
PCR  
For isolation of total RNA from wound tissue or fibrotic tissue, the tissue was 
homogenized in a mixer mill, and RNA was extracted using the RNeasy Fibrous Tissue 
Kit. Total RNA from monocytes/macrophages was isolated using the RNeasy Mini Kit as 
per manufacturer’s instructions. The RNA concentration was determined by 
spectrophotometric measurement and calculated by standard equation: RNA (µg/ml) = 
OD (260) * 40 * dilution factor. 500-1000 ng of each RNA sample was reversely 
transcribed using the High Capacity cDNA RT Kit according to the manufacturer’s 
protocols.  
Quantitative real time PCR was performed with Power SYBR Green PCR mix in triplicates 
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using 7300 Real Time PCR system. S18 (18S rRNA subunit; ribosomal protein S18) as a 
housekeeping gene and efficiency matched primers of the target genes were used for the 
RT-PCR. The comparative method (ΔΔCT) of relative quantification was used to 
determine the expression levels of target genes normalized to the housekeeping gene 
S18. Data were expressed as fold change over control wounds or PBS injected fibrotic 
skin or blood monocytes. Wherever possible, exon spanning primers were designed with 
an annealing temperature of 60°C ± 1°C using either NCBI primer BLAST or Roche 
Universal primer design software. All the used oligonucleotides are listed in table 5-3. 
Master mix for quantitative real time PCR 
SYBR Green mix 10 µl 
Forward primer 0.5 µl 
Reverse primer 0.5 µl 
Double distilled H2O 8.0 µl 
cDNA 1.0 µl 
 
Quantitative real time PCR program  
50°C  2 min 
95°C  10 min 
 
95°C 
60°C 
 
15 s 
60 s           30 x  
  
72°C  10 min 
4°C  Pause 
Default dissociation curve program was used for melting curve. 
5.2.5 Separation of epidermis and dermis 
Bleomycin injected fibrotic skin and PBS injected skin were used for the separation of 
epidermis and dermis. The skin was incubated with 0.5 M ammonium thiocyanate, pH 6.8 
for 35 minutes on ice and subsequently, the epidermis was scrapped off. The separated 
epidermis or dermis was kept in either RNAlater® solution for RNA isolation or the dermis 
was used immediately for the analysis of the total collagen content. 
5.2.6 Culture and maintenance of peritoneal macrophages  
Isolation of peritoneal macrophages for culture and stimulation was performed under 
sterile conditions as described in the section 5.2.1.1.1. The cells were re-suspended in 
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DMEM medium supplemented with 10% FCS and penicillin-streptomycin (100 U/ml 
penicillin and 0.1 mg/ml streptomycin). A minimum 1*106 cells per ml was seeded into the 
6 well plate dishes and incubated for 4 h in an incubator supplied with 5% CO2 at 37°C. 
Non-adherent cells were removed by washing two times with fresh DMEM medium. 
Macrophages were starved overnight in DMEM supplemented with 1% FCS before 
stimulation with recombinant human TGF-β1 for 10 minutes, 20 minutes and 30 minutes 
and lyzed for western blot analysis. 
5.2.7 In vitro random migration and analysis 
Peritoneal cells were harvested and cultured as described in the section 4.2.7. To analyze 
random migration macrophages were cultured in 24 well plate at a cell density 1*106 per 
well in DMEM medium supplemented with 1% FCS and 10% FCS. The cells were kept 
under Olympus 1X81 microscope under humidified chamber supplemented with 5% C02 
at 370C for 48 h. The trajectory length travelled by macrophages was analyzed using 
manual tracking plug-in from ImageJ software.  
5.2.8 Southern blot 
5.2.8.1 DNA digestion 
5-10 µg isolated DNA from peritoneal macrophages were digested in a reaction volume of 
50 µl containing 1X Tango buffer, 2 U of the restriction enzyme Nco1 overnight at 38°C. 
The digested DNA was resolved by agarose gel electrophoresis on 0.7% agarose gel at 
50 V. The resolved gel was kept in denaturation buffer, washed in distilled water and 
transferred onto a nitrocellulose membrane.  
5.2.8.2 Transfer of DNA on nitrocellulose membrane and pre-hybridization 
To transfer the gel on nitrocellulose membrane, the transfer apparatus was set in the 
following order:  
3 sheets of gel-size whatmann paper pre-soaked in transfer buffer 
Pre-run gel (upside down over the whatmann paper) 
Nitrocellulose membrane (gel size) 
3 sheets of whatmann paper 
Paper towels (as many so that it do not get wet)  
A weight for efficient transfer 
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The whole assembly was kept overnight at room temperature for the transfer of DNA on 
nitrocellulose membrane followed by baking in an oven at 800C for 2 h. Subsequently, the 
blot was washed with distilled water, inserted in a hybridization roller bottle with 10 ml of 
QuickHyb hybridization solution and incubated inside the hybridization oven at 600C for 1 
h. Meanwhile, Radioactive labeled probed was prepared as described in the next section. 
5.2.8.3 Generation of TGFβRII specific probe and purification 
To generate the probe and labeled with radioactive (P32)-α-dCTP, genomic DNA was 
amplified using TGFβRII exon 2 specific primer for probe labeling. 
Master mix for exon 2 amplification 
10 X buffer 2.5 µl 
dNTP mix  0.5 µl 
Forward primer 0.5 µl 
Reverse primer 0.5 µl 
MgCl2 2 µl 
Taq DNA polymerase 0.25 µl 
Distilled water 17.75 µl 
Genomic DNA 1 µl 
 
 
PCR program for exon 2 amplification 
95°C  5 min 
95°C  45 s 
56°C  60 s    33 x 
72°C  60 s 
72°C  7 min 
10°C  Pause 
After amplification PCR, 10 µl of PCR product was loaded and run on 1.5% agarose gel at 
120 V. The amplified product was cut out of the gel with sharp scalpel and purification 
steps were performed using QIAquick gel extraction kit according to the manufacturer’s 
protocol. The obtained purified DNA was measured and used for radioactive probe 
labeling. 
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5.2.8.4 Radioactive probe labeling and purification 
100 ng of the purified exon 2 amplicon (section 5.2.8.3) was mixed with 2 µl of random 
primer (provided with the labeling kit) denatured to 950C for 5 minutes followed by cooling 
on ice for 5 minutes. To label the probe Takara labeling kit was used as detailed in the 
manufacture’s protocol.  
Master mix for probe labeling 
10 X buffer 5 µl 
dNTP mix (0.2 mM each, without dCTP) 2.5 µl 
Bca DNA polymerase (2U/µl) 1 µl 
(P32)-α-dCTP (radioactive labelled) 2.5 µl 
DNA with incubated random primer 15-17 µl 
The radioactive labeled probe was purified on Illustra ProbeQuant G-50 microcolumns 
column (supplied with the kit).  
5.2.8.5 Hybridization and detection 
100 µl of salmon sperm DNA was added to the labeled probe, heated to 950C for 5 
minutes, cooled on ice and then added to the hybridization bottle containing nitrocellulose 
membrane with transferred digested DNA and incubated overnight at 630C inside the 
hybridization oven. Subsequently, the membrane was washed with 2X SSC containing 
0.1% SDS at room temperature and the radioactivity was measured with the scintillation 
counter followed by additional washing with 0.1x SSC containing 0.1% SDS at 650C until 
the radioactivity value drops to 0.6 bq/cm2 as measured by Contamat FHT 111M. The 
membrane was then exposed to X-ray film. The expected size of the floxed band was 2.9 
kb, wild type band was 2.7 kb and deleted band was 1.8 kb on the film.  
5.2.9 Western blot 
5.2.9.1 Sample preparation and SDS-PAGE (Sodiumdodecyl-sulphate-
polyacrylamide-gel electrophoresis 
For Western blot, cultured macrophages stimulated with rTGF-β1 were lysed in RIPA 
buffer supplemented with protease inhibitor cocktail and phosphatase inhibitor and 
incubated for 1 h at 4°C. The sample was pre-cleared by centrifugation at 13,000 rpm and 
4°C and supernatant was used to determine protein concentration by BCA assay to 
ensure equal protein loading. The samples (30-50 µg) were reduced in sample loading 
buffer containing 20% β-mercaptoethanol by heating for 10 minutes at 95°C. SDS-PAGE 
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was performed following the modified protocol of Laemmli (Laemmli 1970) using 4-12% 
Bis-Tris SDS-PAGE gels (NuPAGE® Novex®, Invitrogen). Electrophoresis was performed 
at 200 V for 45 minutes in the Xcell SureLock® Mini-Cell system using MES running 
buffer.  
5.2.9.2 Protein-transfer and detection 
Proteins resolved by SDS-PAGE were transferred to a PVDF membrane using a tank blot 
system (SureLock System and Tank blot module, Invitrogen). Before use, the PVDF 
membrane was activated with methanol. The blotting module with no air bubbles. The 
blotting module contained cathode- 2 transfer sponge- 4 pieces of Whatman filter paper- 
SDS-PAGE gel- PVDF membrane- 4 pieces of Whatman filter papers- 2 transfer sponges- 
anode. All components were soaked with transfer-buffer before use. The transfer was 
performed for 1.25 h at 30 V.  
Immunodetection was performed by blocking the PVDF membrane with 5% dry milk in 
TBS supplemented with 0.05% Tween-20 (TBS-T) for 45 minutes, followed by overnight 
incubation with appropriately diluted primary antibody at 4°C (table 5-1). Equal protein 
loading was detected using actin as a loading control. The membrane was stripped in 
stripping solution for 5-10 minutes, blocked and re-probed with primary antibody against 
actin and incubated for 1.5 h at room temperature. 
After incubation, membrane was washed with TBST (15*3) and probed with HRP- 
conjugated secondary antibody for 1 h at room temperature, washed and protein bands 
were visualized by western lightning chemiluminescence. The chemiluminescence signal 
was detected on X-ray film. 
5.2.10 Histology  
5.2.10.1 Histochemistry, Sirius red and Giemsa staining 
Skin samples were fixed in 4% formalin over night and embedded in paraffin. 6 µm 
sections were stained with hematoxylin/eosin (H&E), Giemsa stain, and Sirius Red stain 
following standard protocols in a routine histology laboratory of University hospital of 
Cologne.  
H&E staining was used for an overview and quantification of common wound healing 
parameters and bleomycin induced fibrotic skin. In this case Hematoxylin stains basophilic 
structures such as nucleic acids purple, whereas eosin stains eosinophilic structures like 
the cytoplasm and protein pink, and erythrocytes red.  To analyze collagen fibers, Sirius 
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Red staining was performed and visualized under polarized light. Giemsa staining was 
used to score mast cells infiltration, which obtained dark purple cytoplasmic granule 
staining. 
5.2.10.2 F4/80 staining on cryosections. 
10 µm cryosections were fixed in ice-cold acetone for 2 min, washed with PBS (3*5’) and 
blocked with 10% normal goat serum in PBS containing 5% BSA for 1 h at room 
temperature. Sections were then incubated for 2 hours at room temperature with primary 
antibody F4/80, diluted in Dako antibody diluent, washed with PBS (4*15) and incubated 
with Alexa-488 conjugated Goat-α-Rat secondary antibody dilute in Dako antibody diluent 
for 2 h at room temperature. Nuclei were visualized using 1 µg/ml DAPI solution. The 
sections were mounted with Gelvatol. 
5.2.10.3  α-SMA/CD31 staining 
Cryosections were fixed in ice-cold acetone for 2 minutes, air dried for 20-30 minutes, 
washed with PBS for 10 minutes and blocked with 10% fetal calf serum for 30 minutes at 
room temperature.  The sections were then probed with primary antibody Rat-α-CD31 
diluted in 10% FCS/PBS, washed with PBS (4*10’) and incubated with Alexa-488 
conjugated secondary antibody Goat-α-Rat for 2 h at room temperature. To double stain, 
the sections were simultaneously incubated with Cy3 conjugated mouse-α-SMA primary 
antibody and 1 µg/ml DAPI in 10% FBS/PBS to visualize the nuclei. Sections were then 
washed with PBS (4*10’) and mounted with gelvatol. 
5.2.10.4 Gr-1 staining 
Cryosections were fixed in ice-cold acetone for 3 minutes, washed with PBS (3*5’), 
incubated with endogenous peroxidase blocking solution, blocked with 10% FCS for 30 
minutes and probed with primary antibody Rat-α-Gr-1 diluted in 1% BSA/PBS overnight at 
4°C. The sections were then washed with PBS (4*15’), incubated with HRP-conjugated 
secondary antibody Goat-α-HRP diluted in 1% BSA/PBS for 1 h at room temperature, 
washed with PBS (4*15’) and incubated with few drops of aminoethyl carbazole (AEC) 
substrate solution for 5-20 minutes at room temperature. The sections were then washed 
with tap water for 5 minutes and counterstained with Hematoxylin. 
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5.2.11 Morphometric analysis 
5.2.11.1 Quantification of wound healing parameters and bleomycin induced 
fibrosis 
The microscopic wound area and fibrotic dermal thickness were quantified on H&E 
stained paraffin sections using Leica DM4000B light microscope (Leica Microsystems, 
Wetzlar, Germany; Diskus 4.50 Software, Diskus, Königswinter, Germany). The 
measurement of the distance between the two epithelial tips was used to determine the 
extent of epithelialization. The measurement of the distance between the ends of the 
panniculus carnosus was used as a measure of wound contraction. In bleomycin induced 
fibrotic skin, the dermal thickness was determined to quantify the fibrotic response. 
5.2.11.2 Quantification of histochemical stainings  
Organization and maturation of collagen bundles was assessed on paraffin sections of 
day 14 wounds and fibrotic skin (2 weeks and 4 weeks of bleomycin injection) stained with 
Sirius Red and visualized by polarized light (Leica DM4000B, Leica Microsystems, 
Wetzlar, Germany). To determine the number of mast cells and Gr-1 positive neutrophils, 
the stained cells were counted in the entire area of fibrotic tissues. 
5.2.11.3 Quantification of immunohistochemical stainings  
Immunofluorescence microscopy was conducted using Eclipse 800E Microscope; Nikon, 
Melville, NY, USA). Number of macrophages was determined by counting cells in the total 
granulation tissue and at the wound edges. For quantitative analysis of CD31 and α-SMA, 
the area in the granulation tissue, which stained positive were calculated using analysis 
ImageJ software (Wayne Rasband, National Institute of Mental Health, Bethesda, MD, 
USA).  
5.2.12 In situ zymography 
In situ Zymography was performed on the cryosections of fibrotic skin. Gel containing 30% 
polyacrylamid, 5% of bovine gelatine, 10% APS and TEMED in Tris-HCl buffer was 
polymerized on the slides and kept in humid chamber. 8 to 10 µm thick cryosections were 
cut and placed on the gelatine gel and incubated overnight in a humid chamber at 370C. 
Subsequently, the sections were stained with methylene blue for 1 minute and washed 
with distilled water. Pictures were taken under the microscope and coordinates are 
measured. The sections were removed from the gel using soft tissue and 5% SDS at 500C 
and the tissue incubated gelatine slides were washed in distilled water, stained with 
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Coomassie blue for 10-20 minutes, destained in distilled water. The white spots against 
the dark blue gelatine background were used as an indication of enzyme activity.  
5.2.13 In vivo experiments 
5.2.13.1 Mouse strains  
Mouse strains were maintained and bred under standard pathogen-free conditions as per 
institutional guidelines. To generate TGFβRII
fl/fl
LysMCre mice, TGFβRII floxed mice 
(TGFβRII
fl/fl
) (Cazac and Roes 2000) were crossed with a transgenic mouse line 
expressing Cre recombinase under myeloid cell specific lysozyme M (LysMCre) promoter 
(Clausen, Burkhardt et al. 1999). TGFβRII
 
floxed mouse strain was maintained on a mixed 
C57/Bl6 & SV129 background, and LysMCre was maintained on a C57/Bl6 background. 
5.2.13.2 Genotyping  
Isolated Genomic DNA from three weeks old mice was used for genotyping PCR as 
described in the section 5.2.3. The PCR program used for genotyping is listed below and 
the primer sequences are listed in the table 5-4.  
Genotyping master mix 
Mix TGFβRII & LysMCre 
10X buffer 2.5 µl 
dNTP´s  0.5 µl 
FP1 0.5 µl 
RP1 0.5 µl 
MgCl2  2 µl 
Taq-Polymerase 0.25 µl 
Double distilled H2O 18.25 µl 
cDNA 1 µl  
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Genotyping PCR program 
Temperature TGFβRII & LysMCre 
95°C  5 min 
95°C  45 s 
56°C  60 s    12 x 
72°C  60 s 
95°C  45 s 
52°C  60 s    18 x 
72°C  60 s 
72°C  7 min 
10°C  Pause 
 
5.2.13.3 Thioglycollate-induced peritonitis and peritoneal cell harvest 
To induce peritonitis, 4% of thioglycollate in PBS was prepared, autoclaved and matured 
in the absence of light in a dark bottle for at least six months before use. Mice were 
injected with 1 ml of 4% thioglycollate and peritoneal cells were harvested from peritoneal 
cavity four days after injection (section 5.2.1.1.1). 
5.2.13.4 Wounding  
Mice were anesthetized by intra-peritoneal injection of ketanest/2%Rompun. Four full 
thickness wound of 6 mm diameter were generated on the shaved back of mice using a 
standard biopsy punch. At day 4, day 7 or day 14 post injury and tissues were collected. 
For histological analysis, the tissue were bisected in caudocranial direction and was either 
fixed overnight in 4% paraformaldehyde or embedded in OCT compound for 
immunohistochemical staining. Serial sections from the central portion of wounds were 
used for histological analysis. For RNA isolation, tissues were excised and stored in 
RNAlater® solution at -20°C. For cell isolation, wound tissues were excised and 
processed immediately. 
5.2.13.5 Bleomycin induced fibrosis 
Cutaneous fibrosis was induced by intra-dermal injection of 100 µl of 1 mg/ml bleomycin 
everyday for five days per week until 2 weeks and 4 weeks on the shaved back. Tissue 
was excised and used for histological studies, RNA isolation and cell isolation.  
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5.2.14 Statistical analysis  
Statistical analysis was performed using GraphPad Prism5 (GraphPad Software, Inc., San 
Diego, CA, USA). Statistical significance was analyzed using unpaired student’s t-test. P ≤ 
0.05 was considered significant. 
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7 Abbreviations 
7-AAD  Aminoactinomycin D  
APC   Allophycocyanin  
APS Ammonium persulfate 
α-SMA   Alpha-smooth muscle actin  
bFGF  Basic fibroblast growth factor  
Bleo Bleomycin 
bp  Base pairs  
BSA  Bovine serum albumin  
°C Degree Celsius 
CCL  Chemokine (C-C motif) ligand  
CD  Cluster of differentiation  
CSF-1 Colony stimulating factor  
cDNA Copy deoxyribonucleic acid  
CTGF Connective tissue growth factor 
DAPI 4’,6-diamidino-2-phenylindole  
DC Dendritic cell  
der Dermis 
DMEM Dulbecco’s modified eagle medium  
DNA Deoxyribonucleic acid  
DT Diphtheria toxin 
Epi Epidermis 
ECM Extracellular matrix  
EDTA Ethylenediaminetetraacetic acid 
ERK Extracellular signal-regulated kinase 
FACS Fluorescence activated cell sorting 
FCS Fetal calf serum 
FITC Fluoresceinisothiocyanat 
fl Floxed 
g Granulation tissue 
H&E Hematoxylin and eosin stain 
HPF High power field  
ICAM Intercellular adhesion molecule 
IFN-γ  Interferon-γ 
i.p Intraperitoneal 
iDTR Inducible diphteria toxin receptor 
IL Interleukin 
iNOS Inducible nitric oxide synthase 
JNK c-Jun N-terminal protein kinase 
kb Kilo base pairs  
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kDa Kilo Daldon 
LysM Lysozyme M 
MΦ Macrophage 
MCP-1 Monocyte chemotactic protein-1 
MES 2-(N-morpholino) ethanesulfonic acid 
mg Milligram 
µl Microlitre 
µm Micrometer 
MIP-1α Macrophage inflammatory protein  
min Minute 
MMP Matrix metalloprotease 
NK cells Natural killer cells 
p-value Probability-value 
PAGE Polyacrylamide gel electrophoresis 
PAI Plasminogen activator inhibitor 
PBS Phosphate buffer saline 
PC Panniculus carnosus 
PCR Polymerase chain reaction 
PDGF Platelet-derived growth factor 
PE Phycoerythrin 
PFA Paraformaldehyde  
PMSF Phenylmethylsulphonylfluorid 
qPCR quantitative polymerase chain reaction 
RNA ribonucleic acid  
RPM Rounds per minute 
RT-PCR Reverse transcriptase polymerase chain reaction 
S Second 
S18 ribosomal protein S18 
SDS Sodium dodecyl sulphate 
Ser Serine 
Tm Annealing temperature 
TAE Tris base acetic acid EDTA  
TE Tris base EDTA 
TEMED Tetramethylethylenediamine 
TGF-β1 Transforming growth factor-beta 
TGFβRII Transforming growth factor-beta  receptor II 
TIMP Tissue inhibitor of metalloproteinases 
TNF-α Tumor necrosis factor-alpha 
VEGF Vascular endothelial growth factor 
V Volt 
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W Wound tissue 
WMΦ Wound macrophages 
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